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ABSTRACT  
   
This study examined the effect of consuming pinto, black, and dark red 
kidney beans with white rice in comparison to a white rice only control meal on 
the glycemic response of adults with type 2 diabetes (T2D). These bean and rice 
combinations are part of many traditional diets. Seventeen subjects with T2D 
treated by diet and/or metformin were randomly assigned to 4 treatments: white 
rice (control), pinto beans/rice, black beans/rice, and dark red kidney beans/rice. 
All treatments were portioned by weight and matched for available carbohydrate 
content of ~50 grams. Capillary whole blood samples were collected at baseline 
and at 30, 60, 90, 120, 150 and 180 minutes posttreatment and assessed for 
glucose concentration using the YSI Stat Plus Analyzer. Net change glucose 
responses were significantly lower for the pinto, black, and dark red kidney bean 
and rice meals than control at 90, 120 and 150 minutes posttreatment (P < 0.05). 
Incremental area under the curve (iAUC) values were also significantly reduced 
for the bean/rice meals containing pinto (P < 0.01) and black beans (P < 0.05) in 
contrast to the rice control. Results suggest that the combination of whole beans 
and rice may be beneficial to those with T2D to assist with blood glucose 
management. 
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CHAPTER 1 
INTRODUCTION 
The Centers for Disease Control (CDC) estimate that 25.8 million people, 
or approximately 8% of the population in the United States, have been diagnosed 
or have undiagnosed type 2 diabetes mellitus (T2D).
  
 This disease affects a 
disproportionate number of Hispanics (11.8%) and African Americans (12.6%) 
(CDC, 2011). Diet and lifestyle changes are the first intervention steps 
recommended by leading health agencies to control T2D. Dietary modifications 
have the added benefit of improving overall health and reducing the risk of other 
nutrition-related chronic diseases such as cardiovascular disease, hypertension, 
and cancer (O’Keefe & Bell, 2007; Eckel, Kahn, Robertson & Rizza, 2006).   
Many persons with T2D fail to reach glycemic control goals. Despite the 
known benefits of lifestyle change, there is often poor adherence to dietary 
recommendations (Knowler et al., 2002; Herman et al., 2005; Knight, Dormant & 
Bundy, 2006; Vijan et al., 2004). Difficulty meeting dietary guidelines is a 
frequently reported concern,
 
particularly among Hispanic (Caban, Walker, 
Sanchez & Mera, 2008; Rustveld et al., 2009; Wen, Parchman & Shepherd, 2004, 
McCloskey & Flenniken, 2010)
 
and African American populations with T2D 
(Two Feathers et al., 2005; de Groot et al., 2003). Two dietary adherence barriers 
often mentioned are exclusion of cultural foods and the inability to eat the same 
foods as the rest of the family (Caban et al., 2008; Rusveld, Pavlik, Jibaja-Weiss, 
Kline & Gossey, 2009; de Groot et al., 2003).
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Epidemiological studies have shown associations with decreased legume 
consumption and increased rates/prevalence of chronic diseases, including T2D 
(Leterme, 2002; Darmadi-Blackberry et al., 2004; Bazzano et al., 2001). Beans 
have a low glycemic index (GI) which by definition means they reduce the rise in 
glucose after a meal (Brand-Miller, Hayne, Petocz & Colagiuri, 2003; Bornet et 
al., 1987; Sievenpiper et al., 2009).  In contrast, high GI items like white rice can 
cause postprandial glycemic elevations that are damaging to vascular tissues and 
other organs (Sugiyama, Tang, Wakaki & Koyama, 2003; Ceriello et al., 2008). In 
mixed-meal settings, beans combined with a high GI or refined carbohydrate food 
produced a glycemic response that is intermediate between the high and low GI 
foods (Bornet et al., 1987; Sugiyama et al., 2003; Winham, Hutchins & Melde, 
2007).
 
 These findings have important implications for chronic disease risk 
reduction since elevated blood glucose is a contributor to cardiovascular risk 
(O’Keefe & Bell, 2007; Ceriello et al., 2008). Inclusion of culturally familiar 
beans in the therapeutic diets of immigrants and minorities with T2D may 
decrease postprandial glycemic variability, maintain vascular health, and improve 
dietary compliance and quality of life (Knight et al., 2006; Vijan et al., 2004; 
Caban, Walker, Sanchez & Mera, 2008; Jimenez-Cruz, Loustaunau-López, 
Bacardi-Gascón, 2006). 
Phaseolus vulgaris species such as pinto, dark red kidney and black beans 
with rice are classic food combinations in many areas of the world, especially in 
the Caribbean, Latin America, Middle East, and Mediterranean (Leterme, 2002). 
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Beans have been customarily eaten with cereal grains or maize in societies dating 
back to the Aztecs, Mayas, Incas and local native populations within Central 
America (Leterme & Munoz, 2002). Beans are low in fat and high in fiber, 
vegetable protein, folate, iron, magnesium, zinc, omega-3 fatty acids, and 
antioxidants (Leterme, 2002; Darmadi-Blackberry et al., 2004; Mitchell, 2009. 
They also contain phytate and phenolic compounds that may function in similar 
ways to alpha glucosidase or alpha amylase inhibitor T2D medications like the 
oral hypoglycemic agent acarbose (Tormo, Gil-Exojo, de Tejada & Campillo, 
2004; Sievenpiper et al., 2009).
 
The retention of beans in the diet may have 
positive implications for those with T2D, as beans are known low GI foods, in 
that they produce an attenuated blood glucose increase after consumption in 
comparison to a reference food such as white bread (Rizkalla, Bellisle & Slama, 
2002).  
Purpose of study 
The primary objective of this study was to determine the effects of 
consuming three bean types (pinto beans, black beans and dark red kidney beans) 
on the postprandial glycemia of adult individuals with non-insulin-dependent T2D 
using a placebo-controlled 4 x 4 randomized block study design. This study 
appears to be one of the first to look at the effect of these culturally appropriate 
beans for the Americas combined with rice among people with T2D.  
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Research aims 
This research aimed to determine if pinto beans, black beans and dark red 
kidney beans will affect the glycemic responses of individuals with T2D when 
consumed as part of a high GI meal containing white rice. If the beans studied do, 
in fact, improve postprandial metabolic control in the participants studied, they 
could be used as an effective, inexpensive, nonpharmacologic method to assist 
diabetics in the maintenance of appropriate blood glucose and insulin levels, 
which can help to prevent or slow the advancement of the disease. 
Those with T2D are often given conflicting information about beans or 
told not to eat them at all due to their carbohydrate content. If the dietary 
treatments prove effective at controlling blood glucose levels, the study results 
can also be useful for clarifying and directing the dietary recommendations to 
individuals with T2D to promote consumption of this low-cost, culturally 
acceptable food type.  
Hypotheses 
 Bean consumption as part of a high GI meal will reduce postprandial 
blood glucose levels in individuals with non-insulin dependent T2D, as 
compared to a white rice control with a matched available carbohydrate 
content of 50 grams.  
 The glycemic responses will not differ between bean treatments. 
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Definition of Terms 
Glycemic Index- The Glycemic Index is a classification system for foods 
of known available carbohydrate content.  It measures the blood glucose response 
produced after the consumption of these foods in comparison to a known 
reference food such as glucose or white bread.   
Glycosylated hemoglobin A1c - Hemoglobin A1c (HbA1c) is a form of 
hemoglobin that interacts with glucose. This parameter estimates the average 
blood glucose levels over an approximately three month period. 
Delimitations 
Research participants were recruited from the metro Phoenix area. 
Participants were between 35 and 70 years of age, had a body mass index (BMI) 
value between 22-40kg/m
2
, were physician diagnosed with non-insulin dependent 
T2D for at least 6 months, and managing their diabetes using the oral 
hypoglycemic agent Glucophage (metformin) and/or through diet and exercise.  
Limitations 
The results of this study only apply to individuals with non-insulin 
dependent T2D. Results are not applicable to those with insulin-dependent T2D, 
healthy individuals or those with other chronic diseases. A convenience sample 
was used, making the study results less generalizable to the larger American 
population with T2D.  
Recruitment efforts included grocery stores, doctor’s offices, 55+ 
communities and neighborhoods near the ASU Polytechnic campus. While 
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participant food intake was monitored through the use of 24 hour dietary records 
and food frequency questionnaires, it was impossible to get a completely accurate 
assessment. It is also possible that participant compliance with fasting and dietary 
changes wavered during the course of the study, leading to potential errors in the 
data collected. 
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CHAPTER 2 
REVIEW OF LITERATURE 
The Centers for Disease Control (CDC) estimate that 25.8 million people 
have diabetes, or around 8% of the population in the United States. Almost all of 
these individuals (90-95%) are affected by T2D (CDC, 2011). T2D is progressive 
condition characterized by inappropriate insulin action and/or inadequate insulin 
production. Pancreatic beta cells are gradually destroyed as the disease 
progresses, reducing the amount of insulin released and resulting in chronically 
high blood glucose levels (ADA, 2009). Recurring hyperglycemia produces a 
deterioration of body tissues, leading to an increased risk for chronic conditions 
including cardiovascular disease, kidney disease, neuropathy, retinopathy and 
blindness (American Diabetes Association, 2009). In fact, diabetes complications 
are currently the seventh most common cause of death in the United States (CDC, 
2011). Maintenance of proper blood glucose levels over time is of the utmost 
importance to avoid these serious, life-threatening problems.  
Beans are the large seeds of flowering plants included in the Fabaceae 
family. They are commonly consumed traditional foods within many cultures 
around the world, especially in Latin America, the Mediterranean and Middle 
East (Leterme, 2002).
 
Beans have been customarily eaten with cereal grains or 
maize in societies dating back to the Aztecs, Mayas, Incas and local native 
populations within Central America (Leterme & Munoz, 2002). Pinto, black and 
dark red kidney beans are popular bean types within the United States and are 
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frequently consumed with rice in traditional diets (Sugiyama et al., 2003). The 
retention of beans in the diet may have positive implications for those with T2D, 
as beans are known to have low GI values, in that they produce an attenuated 
blood glucose increase after consumption in comparison to a reference food such 
as white bread (Rizkalla et al., 2002).  
The 2010 Dietary Guidelines for Americans recommends that all adults in 
the United States consume 1 ½ cups of beans per week, or around a ¼ cup per day 
(USDHHS & USDA, 2010). This recommendation was reduced from the 2005 
DGA guidelines of ½ cup daily (USDHHS & USDA, 2005). The 2010 DGA 
committee cited reasons such as low intakes of beans by American consumers and 
lack of sufficient scientific evidence to support inclusion of more beans daily 
(USDHHS & USDA, 2010). Regular bean consumption has been shown to 
increase one’s overall intake of fiber and micronutrients including folate, zinc, 
iron, and magnesium, while decreasing one’s total and saturated fat consumption 
(Mitchell, Lawrence, Hartman & Curran, 2009). A number of studies in those 
with T2D have reported reductions in metabolic parameters such as hemoglobin 
A1c (Brand, Colagiuri, Crossman, Allen & Roberts, 1991) (Jarvi, Karlstrom, 
Grandfeldt, Bjorck, Asp & Vessby, 1999), fructosamine (Jarvi et al., 1999; 
Fontvieille, Rizkalla, Penfornis, Acosta, Bornet & Slama, 1992) as well as short 
and long term glucose and insulin levels (Jarvi et al., 1999; Fontvieille et al., 
1992; Rivellese et al., 1980; Jenkins et al., 1988) when diets containing low GI 
foods, including beans, were consumed.  
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However, a majority of these studies have looked at the metabolic 
responses to mixed meals or low GI diets containing variable types and amounts 
of beans combined with other foods. Little information exists as to the glycemic 
effects of consuming individual bean types as part of a white rice meal by 
individuals with non-insulin dependent T2D. Previous research, conducted in 
healthy subjects, sought to determine the glycemic and insulinemic response to 
pinto beans, navy beans and black eyed peas in the form of a spread (Winham, 
Hutchins & Melde, 2007). A significant reduction in blood glucose and insulin 
levels were not seen, but this may be due to the form in which the treatments were 
given. Conversely, a similar study found a significant reduction in the blood 
glucose and insulin levels of healthy adults after consumption of whole chickpeas 
and black beans with white rice in comparison to a control meal containing solely 
white rice (Thompson, Winham & Hutchins, 2009). The aforementioned research 
design was extended in this study to include individuals with non-insulin 
dependent T2D, and to provided  dietary treatments including three of the most 
popular bean types within the United States: pinto beans, black beans and dark red 
kidney beans (Lucier, Lin, Allshouse & Scott Kantor, 2000). The proposed 
research also included some new parameters, including an analysis of capillary 
blood samples, the use of the Block Fat and Fruit and Vegetables screeners and 
the Block 2005 Food Frequency Questionnaire (FFQ) (NutritionQuest, Berkeley, 
CA) to assess dietary changes and overall quality.  
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Diabetes 
Diabetes mellitus is a condition of insulin inaction and/or improper insulin 
usage (ADA, 2009). Since insulin brings glucose into the cells and converts it to 
energy, alterations in its ability to work cause problems with carbohydrate 
metabolism. Diabetes causes hyperglycemia and a variety of serious side effects 
including heart disease, diabetic retinopathy, nephropathy, peripheral neuropathy 
and dementia (ADA, 2009).  
There are three types of diabetes: type 1 diabetes, gestational diabetes and 
T2D. T2D is the most commonly seen version of diabetes, affecting 90-95% of all 
individuals with diabetes (ADA, 2009). Type 1 diabetes accounts for 5-10% of 
diabetes diagnoses in the United States (CDC, 2007). This condition is primarily 
diagnosed before the age of 30 and is typified by pancreatic beta cell destruction 
leading to a lack of insulin production. Autoantibodies to one or more of the 
following are found in 85-90% of individuals diagnosed with type 1 diabetes: 
insulin, pancreatic beta cells, tyrosine phosphatases and glytamic acid 
decarboxylase (ADA, 2009). A genetic predisposition to type 1 diabetes may also 
be causative in the development of the disease (ADA, 2009). Individuals with 
type 1 diabetes require exogenous insulin to prevent diabetic ketoacidosis, coma 
and death. Gestational diabetes is a condition of altered carbohydrate metabolism 
that occurs during pregnancy. This type of diabetes is most often diagnosed 
through the use of a 75g oral glucose tolerance test between the 24
th
 and 28
th
 week 
of pregnancy for women considered to have a low to medium risk of developing 
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the condition (ADA, 2009). It is recommended that women thought to be at high 
risk of developing gestational diabetes should be tested earlier in pregnancy in 
order to prevent complications to the mother and fetus (ADA, 2009). Women who 
have had gestational diabetes during a previous pregnancy have approximately a 
35-60% likelihood of developing type 2 diabetes compared to women who have 
not had this condition (CDC, 2011). Gestational diabetes occurs in 4% of all U.S. 
pregnancies and may affect anywhere from 1-14% of the population, depending 
on the area sampled. 
T2D occurs when insulin sensitivity and/or production is gradually 
diminished, ultimately requiring specific dietary management, medications and 
other treatments to control chronic hyperglycemia. Insulin insensitivity can occur 
due to many factors but primarily happens due to obesity/overweight (BMI >30) 
or advanced age. While only around 4% of individuals aged 20 to 44 years have 
diagnosed or undiagnosed diabetes, almost 30% of individuals 65 years of age or 
older have this condition (CDC, 2011). Impaired fasting glucose is defined as a 
fasting pre-prandial glucose level between 100-125mg/dL. Impaired glucose 
tolerance is determined during an oral glucose tolerance test (OGTT) and is 
diagnosed based on a two hour postprandial glucose level between 140-199mg/dL 
(ADA, 2009).  
The Nutrition Transition 
Diabetes and other Nutrition-related Non-communicable Diseases are 
becoming increasingly common worldwide as countries shift from a traditional to 
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a more “Western” dietary profile through a process called the Nutrition Transition 
(Popkin, 2004). Often this transition occurs due to globalization and increase in 
access to new “Western” foods. Traditional diets are typically considered to be 
healthful and comparatively low energy, containing little fat and saturated fat but 
abundant in fiber, complex carbohydrates, fruits and vegetables (Winham, 2009). 
Conversely, the Western diet contains ample high fat and high carbohydrate foods 
with comparatively low nutrient density to many traditional food patterns 
(Popkin, 2001). With the Nutrition Transition often comes a reduction in the 
consumption of traditional foods like beans, vegetables and whole grains and an 
increase in consumption of animal products such as meat and dairy (Popkin, 
2001). Epidemiological studies have associated low legume consumption with 
increased rates and prevalence of chronic diseases including T2D (Leterme, 2002; 
Darmadi-Blackberry, Wahlqvist & Kouris-Blazos, 2004; Bazzanno et al., 2001).
 
Inclusion of culturally familiar beans in the therapeutic diets of immigrants and 
minorities with T2D may decrease postprandial glycemic variability, and improve 
dietary compliance and quality of life (Knight et al., 2006; Vijan et al., 2004; 
Caban, Walker, Sanchez & Mera, 2008; Jimenez-Cruz, Loustaunau-López & 
Bacardi-Gascón, 2006). 
Dietary Acculturation 
After immigration to a new country, individuals typically acculturate to 
the predominant culture in that country during a multidimensional process called 
acculturation. Acculturation is defined as the adopting of the cultural pattern of 
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the host country such as language, religion and cultural practices (Satia-Abouta, 
Patterson, Neuhouser & Elder, 2002). Dietary acculturation refers to the adopting 
of the predominant food patterns of the dominant country by immigrant minority 
individuals. This is a complicated, dynamic, non-linear process.  
Immigrants may lose the peripheral and perhaps even secondary foods 
common to their traditional diets but often retain the primary staple foods such as 
rice and bread (Satia-Abouta et al., 2002). The evening meal may continue to 
contain traditional foods but breakfast and lunch may be comprised of “Western” 
foods. Frequently plant protein foods like beans and grain foods are replaced by 
animal products. Those with a higher level of education, income and similar 
physical characteristics as those in the host country are less likely to experience 
cultural isolation than those who move to monocultural enclaves with similar 
individuals from their home country (Satia-Abouta et al., 2002). Intakes of fruit, 
vegetables, rice and beans have been found to decrease with acculturation in 
Latino immigrants (Ayala, Baquero & Klinger, 2008). Conversely, fast food and 
fatty foods were found to increase with an increase in acculturation measures. 
Therefore, retention of traditional dietary patterns can be more beneficial for 
recent immigrants as acculturation to a more “Western” style diet has been 
associated with the development of many chronic diseases, including diabetes 
(Satia-Abouta et al., 2002).  
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Prevalence 
As of 2011, 25.8 million people had diabetes, although only 18.8 million 
were ever formally diagnosed with the disease (CDC, 2007). Individuals with 
T2D make up the majority of those with diabetes (ADA, 2009). The number of 
diabetes diagnoses is expected to further increase in the future due to a heightened 
prevalence of overweight, obesity, poor dietary habits and sedentary lifestyles. 
One may be diagnosed with T2D if they meet the following criteria: fasting 
glucose ≥126mg/dL, casual glucose level ≥200mg/dL and/or 2 hour postprandial 
glucose level ≥200mg/dL (ADA, 2002).  
It is estimated that close to 79 million American adults ages 20 and older 
have pre-diabetes, a condition that greatly increases the risk that they will develop 
full-blown diabetes in the future if glycemic control is not maintained via positive 
changes such as weight loss, dietary alterations and an increase in physical 
activity (CDC, 2011; Mahan & Escott-Stump, 2008). Pre-diabetes may be 
diagnosed due to the presence of impaired fasting glucose and/or impaired 
glucose tolerance. Impaired fasting glucose is defined as fasting glucose levels 
between 100-125 mg/dL and impaired glucose tolerance is defined as a 2 hour 
postprandial glucose level between 140-199 mg/dL (Mahan & Escott-Stump, 
2008). 
Risk factors 
A diverse group of risk factors have been associated with the development 
of T2D. Some of these include: advanced age, overweight or obesity (BMI 
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≥25kg/m2), a lack of physical activity, and being part of a high-risk racial or 
ethnic group such as African Americans, Native Americans, Latinos, Alaskan 
Natives or Pacific Islanders. The presence of certain conditions such as 
dyslipidemia (HDL <35 mg/dL or triglycerides >250 mg/dL), hypertension, 
gestational diabetes (delivering a macrosomic infant ≥9lbs a birth), polycystic 
ovary syndrome, impaired fasting glucose and impaired glucose tolerance have 
also been connected to an increased risk of T2D (Mahan & Escott-Stump, 2008).  
Symptoms/Complications 
Individuals with T2D may initially have no disease symptoms. As the 
disease gradually progresses they may, however, experience acute warning signs 
such as polyphagia, polyuria, weight loss, fatigue, irritability, and blurred vision 
(ADA, 2002). Diabetic ketoacidosis is not a frequently seen symptom among 
those with T2D because their level of insulin production exceeds that of those 
with type 1 diabetes (ADA, 2009). Long term complications of diabetes include: 
heart disease, diabetic retinopathy, nephropathy, peripheral neuropathy and 
dementia. Acute and chronic diabetic complications have been associated with 
consistently high blood glucose levels, especially in the postprandial absorptive 
state (Rizkalla, Bellisle & Slama, 2002). Consistent glucose management is 
needed to prevent both acute and chronic diabetic complications.  
Carbohydrate Metabolism  
T2D results from deficits in carbohydrate metabolism. Carbohydrates are 
an important macronutrient group responsible for many functions in the body. 
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They are the body’s main energy source, exist as energy reserves in the form of 
glycogen or fat and provide needed dietary fiber and vitamins and minerals to the 
human diet (Gropper, Smith & Groff, 2009).  
Carbohydrate Types 
Simple carbohydrates include the monosaccharides and disaccharides. 
Monosaccharides are single carbohydrate units. Three types of monosaccharides 
exist: glucose, fructose and galactose. Glucose is the body’s main energy source 
and the primary monosaccharide in the blood (Gropper et al., 2009). Glycogen, a 
storage form of carbohydrate found in the liver and skeletal muscle, is made of 
highly branched glucose units (Gropper et al., 2009). Fructose is a 
monosaccharide located in fruit and galactose is found in milk products.  
Disaccharides consist of two monosaccharide units. These include sucrose, 
lactose and maltose. Sucrose, also known as table sugar, is a combination of 
glucose and fructose. Lactose is made up of glucose and galactose and is located 
in milk products. Maltose is a disaccharide consisting of two glucose units. It is 
produced by the breakdown of larger starch units and can be found in beer and 
other fermented beverages (Gropper et al., 2009). 
Complex carbohydrates consist of the oligosaccharides and 
polysaccharides. Ogliosaccharides are short chains of 3-10 monosaccharide units 
found in foods such as beans and whole grains (Gropper et al., 2009). 
Ogliosaccharides cannot be digested by human enzymes but can be broken down 
by bacteria found in the gastrointestinal system.  
17 
Polysaccharides include starch, glycogen and cellulose. Starch is the main 
form of carbohydrate storage in plants. There are two types of starch: amylose and 
amylopectin. Amylose is the unbranched form of starch consisting of many 
glucose units linked by alpha 1-4 glycosidic bond. Amylopectin contains both 
alpha 1-4 linkages and alpha 1-6 branch points (Gropper et al., 2009). 
Amylopectin is responsible for 80-85% of starch, while amylose makes up the 
other 15-20% (Gropper et al., 2009). Glycogen is the storage form of glucose in 
animals, consisting of extensively branched glucose units. Cellulose is also 
present in plants, but is used to promote cell structural integrity. This 
polysaccharide is made up of glucose units with beta 1-4 glycosidic bonds.  
Carbohydrate Digestion 
Carbohydrate digestion begins in the mouth using the enzyme salivary 
alpha amylase. This enzyme is released from the salivary glands and serves to 
hydrolyze the alpha 1-4 linkages found in amylose starch. Digestion continues in 
the small intestine with the primary used in carbohydrate digestion, pancreatic 
alpha amylase. This enzyme is released from the pancreas and serves to break 
down alpha 1-4 glycosidic bonds. This action produces the smaller carbohydrate 
molecules maltose and limit dextrins (Gropper et al., 2009).  These molecules are 
further hydrolyzed to disaccharides and monosaccharides at the intestinal brush 
border. The enzyme lactase is responsible for cleaving the disaccharide lactose, 
sucrase hydrolyzes sucrose, maltase breaks down maltose and isomaltase 
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hydrolyzes the alpha 1-6 bonds of isomaltose (where the branches of amylopectin 
originated) (Gropper et al., 2009). 
Carbohydrate Absorption 
Di and monosaccharides are absorbed at the intestinal brush border 
throughout the small intestine. Glucose and galactose enter the intestinal mucosa 
through the SGLT1 transporter. This transporter uses the sodium/potassium 
ATPase pump and requires two sodium ions per glucose/galactose molecule 
(Gropper et al., 2009). Fructose is absorbed by facilitated diffusion using the 
glucose transporter GLUT5. Following absorption, all of the monosaccharides 
enter the portal blood through the glucose transporter GLUT2. They then enter the 
liver where they are either metabolized or released into the blood. Fructose and 
galactose are converted to glucose in the liver or used to make energy or other 
substances such as amino acids. In the liver glucose may be used for energy, 
converted to glycogen through a process called glycogen synthesis, used to create 
fatty acids, or amino acids or released into the blood (Gropper et al., 2009).  
At the peripheral tissues, glucose enters using through a number of 
specific transport proteins, either through active transport using SGLT proteins or 
through facilitated transport using GLUT proteins (Gropper et al., 2009). Twelve 
GLUT transport proteins exist, although only GLUT 4 is insulin regulated. The 
primary GLUT transporters include varieties 1, 2, 3, 4, 5 and 7. GLUT 1 is found 
in the red blood cells and fetal tissues, GLUT 2 is found in the liver, kidney, 
pancreatic beta cells, and small intestine, GLUT 3 is found in the brain, GLUT 4 
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is found in the muscle, heart and adipose tissues, GLUT 5 is found in the 
intestines and kidneys. However, it is not currently known where GLUT 7 is 
located within the body. GLUT 4 transport proteins allow for glucose-responsive 
tissues to receive this nutrient. Metabolic alterations produced by insulin 
resistance may make these transporters less active (Gropper et al., 2009). 
T2D results from progressive insulin resistance at the glucose-responsive 
tissues, primarily skeletal muscle. It is thought that this resistance occurs after 
insulin has bound to the cells but before the insulin-binding signal can be 
processed by the cell (Gropper et al., 2009). This may be due to inadequate 
production and/or use of the GLUT glucose transporters. The mRNA for GLUT4 
has been found to be reduced in the adipose of individuals with insulin resistance. 
This also reduces the number of cellular transporters and subsequently reduces the 
amount of glucose that can get in (Gropper et al., 2009). 
Treatment methods for Diabetes 
Overview of pharmacologic methods  
By CDC estimates, 58% of those with T2D treat their condition through 
the use of oral hypoglycemic agents (CDC, 2011). These medications are often 
prescribed when lifestyle modifications fail to bring about long term glycemic 
control. A variety of non-insulin treatment options currently exist for individuals 
with T2D, including: biguanides, the insulin secretagogues sulfonylureas and 
meglitinides, thiazolidinediones, DPP-4 inhibitors, alpha glucosidase inhibitors 
and two recently approved injectable hormonal medications. These medications 
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may be combined as they have multiple modes of action and can be more 
effective used together. 
Biguanides 
This research study will be limited to individuals who are managing their 
blood glucose using the biguanide metformin (Glucophage). This medication 
works at the liver to reduce glucose production, decreases glucose absorption at 
the intestine and increases glucose uptake and use at the peripheral tissues to 
lower insulin resistance (ADA, 2002; ADA, 2011). Metformin does not produce 
hypoglycemia or hyperinsulinemia but may result in abdominal pain and diarrhea 
if taken on an empty stomach (ADA, 2011). 
Insulin Secretagogues 
Insulin secretagogues include sulfonylureas and meglitinides (ADA, 
2009). These medications act directly upon the beta cells of the pancreas to 
heighten insulin production. They also work at the tissues to increase insulin 
sensitivity. Sulfonylureas include first generation medications such as 
Tolbutamide (Orinase) and second generation medications including glimepiride 
(Amaryl), glipizide and glyburide (Diaβeta) (ADA, 2009).  
Thiazolidinediones 
Thiazolidinedione medications such as pioglitazone (ACTOS) and 
rosiglitazone (Avandia) work to reduce insulin resistance at both the hepatic and 
peripheral tissues through activation of peroxisome proliferator activated (PPAR) 
receptors throughout the body (ADA, 2011). PPAR receptors regulate the 
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transcription of insulin responsive genes to improve glucose sensitivity (ADA, 
2009). Regular liver enzyme tests are required when taking these medications.  
DPP-4 Inhibitors 
Sitagliptin (Januvia) and saxagliptin (Onglyza) are part of a category of 
medications known as DPP-4 inhibitors. These medications act on GLP-1, a 
compound that reduced blood glucose concentrations. DPP-4 inhibitors extend the 
half-life of GLP-1, thereby lowering blood glucose without causing hypoglycemia 
(ADA, 2011). 
Alpha Glucosidase Inhibitors 
Alpha glucosidase inhibitors postpone glucose absorption by delaying 
carbohydrate digestion (ADA, 2002; ADA, 2009). Medications that fall under this 
category include acarbose (Precose), and meglitol (Glyset). These medications do 
not affect insulin sensitivity or secretion and have been found to delay diabetes 
progression when used in individuals with impaired glucose tolerance (Chiasson 
et al., 2002). Beans lower the GI of the diet and have been shown to replicate the 
action of alpha glucosidase medications. This may be potentially due to their 
fiber, amylose starch and phytonutrient content (Sievenpiper et. al, 2009).  
Non-Insulin Injectable Medications 
Byetta, or exenatide, is a unique type of injectable hormonal medication 
called an incretin mimetic. It is often used with individuals who have not achieved 
glycemic control with oral medications such as metformin and/or sulfonylureas. 
This medication replicates exendin-4 and works to increase insulin secretion when 
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blood glucose levels are high (ADA, 2011). Byetta is injected with meals and has 
been found to produce weight loss and glycemic control when used appropriately. 
Side effects can include nausea, and hypoglycemia if taken in conjunction with a 
sulfonylurea medication (ADA, 2011).  
Symlin, or pramlintide, imitates amylin, a hormone that is also synthesized 
by the pancreatic beta cells. Amylin works in concert with insulin and glucagon to 
promote glycemic control. Symlin is approved for individuals with type 1 diabetes 
and T2D who are not reaching their goal HbA1c values through use of insulin 
injections. This medication is also injected with meals and has been shown to 
produce weight loss and nausea (ADA, 2011).  
Dietary treatment methods 
Dietary methods are often used previous to or during treatment with other 
diabetes medications to promote long term glycemic control. These methods have 
fewer side effects than oral medications and can be adapted to one’s individual 
dietary preferences. It is has been shown that T2D can be prevented through 
lifestyle changes such as proper diet and regular exercise (Knowler et al., 2002). 
The Diabetes Prevention Program study found that lifestyle changes including a 
low-energy low calorie diet and regular exercise were more effective (58% 
reduction versus 31% for the metformin arm) in lowering diabetes incidence over 
a 2.8 year follow-up than regular intake of metformin or placebo (Knowler et al., 
2002). Many individuals with T2D experience difficulty adhering to lifestyle 
changes and knowledge alone does not equate to positive behavior modifications 
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(Knight et al., 2006). Dietary isolation from friends and family through an 
inability to eat culturally important foods is a major adherence obstacle (Caban et 
al., 2008; Rusveld, Pavlik, Jibaja-Weiss, Kline & Gossey, 2009; de Groot et al., 
2003).  Inclusion of traditional foods, such as beans, within T2D dietary 
recommendations can help to increase dietary adherence and improve glycemic 
control.  
Beans and are often included in various food categories (e.g. starchy 
vegetables, vegetables protein sources) as part of T2D diet prescriptions.  
However, little evidence exists regarding their actual promotion, or lack thereof, 
by Registered Dietitians and other healthcare practitioners (Desrochers & Brauer, 
2001). The American Diabetes Association encourages bean consumption for 
individuals with T2D, considering them to be a starchy vegetable and a “Diabetes 
Superfood” due to their low GI values and ample micronutrients (ADA, 2008; 
ADA, 2011; Leterme, 2002). The ADA states that the type of carbohydrate 
consumed affects postprandial glucose secondary only to the amount of 
carbohydrate consumed and that those with T2D should choose carbohydrate 
foods with a low GI, such as beans, whenever possible (ADA, 2008).  
Carbohydrate Counting 
 Carbohydrate counting is a widely used dietary treatment method for those 
with T2D. The American Diabetes Association recommends some form of 
Carbohydrate Counting as the first step to achieving glycemic control through 
dietary measures. This method promotes mindfulness of carbohydrate 
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consumption and division of carbohydrate foods into 15 gram intervals in order to 
improve blood glucose control (ADA, 2011). Initially, a range of 45-60 grams of 
carbohydrate are recommended per meal. Beans are included as carbohydrate 
containing foods and their consumption is recommended in ½ cup serving sizes. 
As one discovers the level of carbohydrate and specific foods that affect their 
glucose levels, they can adjust their intake accordingly. One’s carbohydrate intake 
may also need to be changed with alterations to one’s medications or exercise 
frequency/duration.  
ADA Exchange List 
The American Diabetes Association Exchange List is a system of food 
exchanges that assists diabetic individuals with meal planning. Dietary 
information is provided for over 700 food items in a booklet compiled by the 
American Diabetes Association (Geil, 2008). Food items are divided by category 
and serving sizes. Four categories (carbohydrates, meat and meat substitutes, fats 
and alcohol) and eight subcategories are included, along with their estimated 
carbohydrate, protein, fat and caloric content (Geil, 2008). Beans are included in 
½ cup serving sizes both within the starch and plant-based protein food groups. 
Carbohydrate foods are divided into starches such as breads, cereals, starchy 
vegetables, fruits, milk as well as sweets, desserts, other carbohydrates and 
nonstarchy vegetables (Geil, 2008). The meat and meat substitutes grouping 
includes four sub-categories that differ in their fat and caloric content: lean, 
medium-fat, high-fat and plant-based proteins. An index is available within the 
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Exchange List booklet for easy access to specific food items. This method for 
dietary control may be somewhat daunting at first due to the complexity of meal 
planning, but would provide one with excellent oversight into what they consume 
daily. 
The Plate Method 
The Plate Method or “Create Your Plate” is a process recommended by 
the American Diabetes Association to promote portion control and healthier food 
choices. “Create Your Plate” encourages those with T2D to divide their plate into 
three sections: half of the plate designated for non-starchy vegetables such as 
lettuce or green beans and a quarter of the plate for starchy foods and meat or 
meat substitutes, respectively (ADA, 2011). However, unlike the ADA Exchange 
List, beans are included only within the starchy foods category and are 
recommended to be consumed in moderation.  
Glycemic Index 
The glycemic index model was developed in the 1980’s as a means of 
classification for the glycemic response of carbohydrate-containing foods (Jenkins 
et. al, 1981; Wolever, Jenkins, Jenkins & Josse, 1991). The GI refers to the 
increase in blood glucose after consumption of carbohydrate foods compared to 
the blood glucose increase from consumption of a reference food, often glucose or 
white bread. GI values are determined through calculation of the iAUC for blood 
glucose of both the test and reference foods, preferably in the same participant to 
avoid potential glucose deviations. Low GI foods typically have a GI below 55 
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(Foster-Powell & Miller, 1995). Moderate GI foods have values between 55 and 
70 and high GI foods have values in excess of 70 (ADA, 2002). Beans, as a 
whole, are considered to be low GI foods and have been found to produce some of 
the lowest glucose responses of any carbohydrate containing foods (Foster-Powell 
& Miller, 1995). The glycemic load is the GI of each individual food multiplied 
by the amount of each food consumed (Riccardi, Rivellese & Giacco, 2008). 
Controversy remains regarding the GI concept. Some researchers have stated that 
the GI may hold little clinical significance due to variability in glycemic 
responses and GI measures across research trials (Hollenbeck & Coulston, 1991; 
Jenkins & Jenkins, 1995). Conversely, other studies have shown that chronic 
consumption of low glycemic load diets containing low GI foods improve the 
metabolic parameters of healthy individuals and those with T2D and reduce one’s 
risk of developing the disease (Riccardi et al., 2008; Granfeldt, Wu & Bjorck, 
2006). 
Meal planning using the Glycemic Index 
The American Diabetes Association suggests that those with T2D increase 
their consumption of foods with a low or moderate GI values as a simple way to 
improve glycemic control (ADA, 2011). This method can be easily combined 
with Carbohydrate Counting. Using this method, one would utilize GI information 
for specific foods from the ADA’s website or from other educational materials 
and intentionally choose foods with a low GI value (i.e. below 55) or a moderate 
GI value (between 55 and 70) instead of high GI foods.  
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Beans  
Definition 
Legumes are part of the Leguminosae family which includes beans, lentils, 
dried peas and peanuts. These foodstuffs have been defined as “annual 
leguminous crops yielding from one to twelve grains or seeds of variable size, 
shape and colour within a pod” by the Food and Agriculture Organization of the 
United Nations (FAO, 1994). Beans are the large seeds of flowering plants 
included in the Fabaceae family. There are an extensive number of bean types 
around the world, including around 619 genera and 18,815 species (Albala, 2007). 
Bean types such as black-eyed peas and mung beans are encompassed within the 
Vigna species and soybeans are included within the Glycine species. Within the 
Fabaceae family, the common bean (Phaseolus vulgaris) refers to a large group 
of beans originating in the New World. P. vulgaris beans are most often used for 
food consumption and include hundreds of different subtypes such as the navy 
bean, green beans and string beans (Albala, 2007). Pinto beans, black beans and 
dark red kidney beans, also members of the P. vulgaris species, are some of the 
most commonly consumed beans in the United States and around the world. 
History 
 Legumes are also often referred to as beans or pulses, depending on one’s 
geographic location. The words used to describe legumes have been taken from 
many parts of the world. The word legume is derived from the Latin “to gather”, 
legere. The origin of the word bean is not known, although it is thought to be 
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derived from the German word bauno or Old Saxon bona (Albala, 2007). Pulse is 
a synonym for bean that was derived from the Roman bean dish called puls. 
Carbon dating has provided records of bean consumption dating back to around 
11,000 BCE (Albala, 2007). Lentils are the bean type first thought to be 
domesticated in approximately 7,000 BCE. The species Phaseolus vulgaris 
originated in Mexico and South America, seen first around 6,000 BCE in the 
mountains of Peru (Albala, 2007). Two sub-species were domesticated in 
different areas: the aborigineus in Peru and the mexicanus in Mexico. Beans were 
vital foodstuffs among the historical societies of the New World, where maize 
was a central staple food. Bean consumption provided the necessary amino acids 
(lysine, isoleucine and tryptophan) not present in maize and supplemented a diet 
containing little meat from sources such as guinea pigs, turkeys and wild animals 
(Albala, 2007).  
The Mayans of South America consumed black beans in dishes containing 
local ingredients such as chili, epazote, ground squash seeds and green onions. 
The Aztecs also grew beans using traditional terraced agricultural techniques. 
Many of their dishes continue to be consumed today within Mexican cuisine. In 
North America, beans of the P. vulgaris species were also a staple food for the 
Native Americans. The Iroquois were said to rely on the “three sisters,” or corn, 
beans and squash as their primary food sources (Albala, 2007). A frequently 
prepared food within the Cherokee tribe was a bean and corn meal loaf that was 
boiled in hickory leaves. This foodstuff and many other traditional foods 
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containing foods are still consumed today (Albala, 2007; Dilis & Trichopoulou, 
2009).   
Nutrient content and health benefits of beans  
Beans contain a number of nutrients that are beneficial for human health. 
These include, but are not limited to, insoluble, fermentable and soluble fiber, 
amylase starch, vegetable protein, calcium, iron and folate (Leterme, 2002; 
Sievenpiper et al., 2009). Beans are good source of the amino acid lysine, but are 
low in methionine, making them an ideal supplement to grain products when 
combined using a grain to bean ratio of 1:2 or 1:4 (Leterme, 2002). Consuming 
beans with lysine deficient but methionine rich cereal grains, such as rice, can 
help to overcome the amino acid inadequacies of both foods (Albala, 2007).  
Beans also contain non-nutritive dietary fiber and resistant starch that may slow 
digestion and absorption of carbohydrate, as shown by Bednar et al. in an animal 
model (Bednar, Patil, Murray, Grieshop, Merchen & Fahey, 2001). Beans are also 
rich in a variety of phytochemicals and antinutrients such as phenols, enzyme 
inhibitors and phytates. These compounds have also been shown to slow 
carbohydrate digestion in a manner similar to alpha glucosidase and alpha 
amylase inhibitors (Sievenpiper et al., 2009; Tormo et al., 2004). Beans also help 
to reduce the GI of the diet which has been shown to improve glucose control. 
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Current consumption patterns  
Bean consumption in traditional diets 
Beans are commonly consumed traditional foods within many cultures 
around the world. They have been customarily eaten with cereal grains or maize 
in societies dating back to the Aztecs, Mayas, Incas and local native populations 
within Central America (Leterme & Munoz, 2002). Of the countries in Central 
and South America, Brazil consumes, on average, the highest amount of beans per 
person. Black beans are the primary bean type consumed in this country (Leterme 
& Munoz, 2002). Individuals in Nicaragua consume the highest amount of beans 
worldwide with an estimated consumption of approximately 25kg per capita 
(Leterme & Munoz, 2002). Rice is often consumed with beans as part of 
traditional meals in many cultures around the world (Sugiyama et al., 2003).  
Traditional consumption of beans and legumes has been established due to 
factors such as geographical isolation and a reluctance to give up long-standing 
dietary practices. Beans and legumes are consumed more frequently by those of 
lower socioeconomic status and by those who live in rural areas (Leterme & 
Munoz, 2002; Kabagambe, Baylin, Ruiz-Narvarez, Siles & Campos, 2005). 
Conversion from a rural to urban lifestyle often leads to a reduction in available 
time and resources to prepare traditional foods. Urban living in general is 
associated with both an increase in consumption of processed foods and animal-
derived foods with and a decrease in consumption of traditional foods such as 
beans (Leterme & Munoz, 2002). Furthermore, many immigrants experience a 
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Nutrition Transition to a more Western style diet in their host country, resulting in 
the gradual replacement of high nutrient-density traditional food with less 
healthful processed high energy food items (Popkin, 2004). 
Bean consumption trends in the United States 
Bean consumption in the United States is much lower than what is 
recommended by health organizations and also lower than consumption levels in 
other countries around the world (Guenther, Dodd, Reedy & Krebs-Smith, 2006). 
Between the years of 1997 and 1999, the USDA’s Economic Research Service 
estimated that individuals in the US consumed 7.7 pounds of beans per year 
(Lucier, Lin, Allshouse & Scott Kantor, 2000). According to NHANES 1999-
2000 data, only a minority of US adults (7.9%) consumed beans daily and the 
average daily consumption ranged from 0.1 to 0.3 ½ cup servings (Mitchell, 
Lawrence, Hartman & Curran, 2009). Lucier et al. (2000) reported that, within the 
1994-1996 Continuing Survey of Food Intakes by Individuals, 14% of individuals 
included ate a minimum of one food including beans over the two day recording 
period. In contrast, 33% of Hispanic individuals consumed beans over those two 
days. However, lentils, split green peas, yellow peas and lima beans were not 
included in the survey, potentially reducing the reported intake (Lucier et al., 
2000). In the United States, the South and West regions have been found to be the 
largest consumers or dried beans. Navy beans, pinto beans and lima beans were 
found to be consumed by those of lower socioeconomic status (Lucier et al., 
2000).  
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Recommended intake  
The 2010 Dietary Guidelines for Americans recommends consumption of 
1 ½ cups of beans per week or around ¼ of a cup daily (USDHHS & USDA, 
2010). The Dietary Guidelines for Americans considers beans to be unique in that 
they can be counted either a vegetable or a protein food. Beans are considered to 
be a vegetable for omnivores and a protein food for vegetarians (alterations to 
overall recommendations for this group includes 1.4 oz. per day for lacto ovo 
vegetarian and 1.9 oz. daily for vegans). However, most people do meet the 
Dietary Guideline recommendations (Guenther et al., 2006; Mitchell et al., 2009). 
The USDA MyPyramid includes dry beans and peas both as part of the vegetable 
and meat and beans groups (USDA, 2011). Included in this category are dry beans 
such as pinto, black and dark red kidney beans and peas such as chickpeas, black 
eyed peas and lentils. The USDA recommends including dry beans and peas in 
the vegetable group if one consumes meat (USDHHS & USDA, 2010). Dry beans 
and peas are included in the meat and beans group for those who consume limited 
meat or those who are vegetarian.  
Glycemic response studies using beans  
Beans consumed alone as part of a mixed meal  
Akhtar and colleagues (1987) tested the glycemic response to seven 
traditional Pakistani food combinations of beans and white flour chapatti bread or 
rice in comparison to a control meal in 14 healthy men and an equivalent number 
of male subjects with T2D. The control meal included bread, egg fried in ghee 
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and milk. Four bean, bread and milk treatments were also tested. These included 
chickpeas, lentils, mung beans (P. radiatus), and urad dahl (P. mungo). The lentil 
and urad dahl treatments were then repeated with white rice substituted for white 
bread. Participants with T2D took their diabetes medications (oral agents and/or 
insulin injections) 5-10 minutes prior to test meal consumption and all treatments 
were eaten within 10 minutes. Blood glucose concentrations were assessed using 
fingerstick blood samples collected at fasting and at 30 minute intervals over a 
three hour testing period. Analysis included peak increase in blood glucose 
concentrations and area under the glucose response curve calculations. The rice, 
milk and urad dahl meal produced the highest glycemic response, followed by the 
control meal in both participant groups (P ≤ 0.05) (Akhtar, Asim & Wolever, 
1987). The chickpea meal produced the lowest glycemic response in the healthy 
participants but an intermediate response in those with T2D. The bread and lentil 
meal produced the lowest average iAUC for the T2D participant group and the 
second lowest response for the healthy participant group. The rice and bean meals 
had, on the whole, a higher glycemic response than the bread and bean meals. The 
researchers thought this may have been due to the use of polished rice, which has 
been shown to produce a higher glycemic response than parboiled rice and the 
chapatti bread (Akhtar et al., 1987). 
Bornet et al. (1987) looked at the glycemic responses to six different foods 
consumed by 18 persons with non-insulin-dependent T2D. Those taking oral 
hypoglycemic agents were allowed to participate. Test meals included kidney 
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beans, lentils, white rice, wheat flour spaghetti, potato and white bread in servings 
providing 50g of available carbohydrate. Each of these carbohydrate rich foods 
was consumed alone with coffee (meal A) and in a mixed meal containing coffee, 
cheese and butter (meal M). A 50g oral glucose tolerance test was used as control. 
Each of the six foods was tested by three participants. Venous blood samples were 
collected at baseline and at 30, 60, 90, 120 and 180 minutes following treatment 
consumption. The researchers found that the GI values for the foods when 
consumed alone were highest for bread (95%), followed by potato (74), spaghetti 
(64), white rice (56), lentils (30) and kidney beans (23). Mixed meals had a 
similar order of GI ranges but were typically around 20% higher than the 
carbohydrate foods consumed alone (Bornet et al., 1987). The mixed meals also 
produced an increased insulinemic index but the treatments continued to be in the 
same order despite this increase. Incremental changes with regard to blood 
glucose and insulin as well as iAUC values were not discussed in detail within the 
manuscript. Dietary treatments were not matched for dietary fiber content, 
causing the researchers to surmise that the fiber content of the beans and lentils 
could have promoted the significantly lower glycemic effect (Bornet et. al, 1987).  
Indar-Brown and colleagues (1992) tested the glucose and insulin 
response to consumption of five ethnically unique mixed meals in 25 healthy 
participants and 17 individuals with non-insulin dependent T2D. A 50g oral 
glucose tolerance test was compared to mixed meals of American, Yemenite, 
Syrian, Polish and Moroccan origin. Each of the meals was standardized to 
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contain 50g of carbohydrate, 15g of protein and 15g of fat and was consumed 
within 15 minutes. Two of these meals also included legumes: Syrian (lentils), 
and Moroccan (chickpeas). Blood samples were collected at baseline and at 30, 
60, 120 and 180 minutes after the meals were consumed. Outcome measures 
included glucose, insulin, total cholesterol and triglyceride concentrations. GI 
values for the meals and iAUC for glucose and insulin were also calculated. Each 
of the mixed meals produced a lower iAUC for blood glucose than control in the 
T2D group (P ≤ 0.01). However, the Syrian dish containing lentils was found to 
have the lowest predicted GI (49), observed glycemic and insulinemic index 
values as well as a significantly lower glucose iAUC than both the glucose control 
and the other test meals within the T2D group (P ≤ 0.01) (Indar-Brown, Noreberg 
& Madar, 1992). IAUC for insulin was also lower for this treatment than the 
Polish treatment, but not for the control treatment. The researchers suggested that 
it was the fiber content of the Syrian meal (although the type of fiber was not 
specified) along with the fiber and starch content of the lentils that exerted the 
glucose lowering effects in these subjects (Indar-Brown et al., 1992). 
Jang and colleagues (2001) studied the glycemic and insulinemic effects 
of consuming a whole grain diet containing black beans over a 16 week period 
compared to a typical South Korean diet containing refined rice. Participants 
included a group of 76 men with coronary artery disease. Twenty one of these 
individuals were found to have T2D. Individuals consuming the bean treatment 
were instructed to substitute refined rice with the a whole grain and black bean 
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powder, brown rice, barley, whole black beans, vegetables and seasonings. 
Participants came to the test site after each 16 week treatment period to take part 
in a 75g oral glucose tolerance test. Venous blood samples were taken before and 
30, 60, 90 and 120 minutes after the glucose test. Fasting glucose and areas under 
the curve for glucose and insulin were found to be significantly reduced following 
the whole grain diet in those without T2D (P ≤ 0.000, 0.000 and 0.022, 
respectively). However, in the T2D group, only fasting glucose and glucose iAUC 
were found to be significant following the whole grain treatment period (P ≤ 
0.023 and 0.021) (Jang, Lee, Kim, Park & Lee, 2001).  
Nestel, Cehun and Chronopoulos (2004) conducted both acute and long-
term six week trials comparing chickpea and wheat based meals in healthy adults. 
Treatments were matched for an available carbohydrate content of 50 grams. 
Nineteen individuals participated in the acute study and a similar number (n = 20) 
took part in the long-term trial. Both trials had an unblinded crossover study 
design. In the acute study, meals were consumed within 10 minutes and blood 
samples were collected at baseline and at 30, 60, 120 and 180 minutes 
posttreatment. Glucose concentrations were found to be significantly lower at 30 
and 60 minutes following the chickpea based meal than after the control meal (P 
≤ 0.05). Significance was also found for plasma insulin at 120 minutes postmeal 
ingestion (P ≤ 0.05). The long term study included three treatments: the 
participant’s normal, or baseline, diet, a higher fiber chickpea based diet and a 
wheat based diet. Blood samples were collected in a similar manner to the acute 
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study during 2 consecutive days at the end of each six week treatment period. 
Significant differences between test meals were not seen for glucose or insulin 
during the long term study, however. This lead the researchers to hypothesize that 
the insulin sensitivity improvements seen in an acute setting may not continue 
over longer term periods in healthy individuals without apparent insulin resistance 
(Nestel et al., 2004).   
Panlasigui et al. (1995) assessed the glycemic response and GI of five test 
meals containing 50 grams of available carbohydrate from chickpeas, black beans, 
mung beans, white beans or pigeon pea, as compared to a control meal containing 
white bread. Eleven healthy individuals participated in this study. All treatments 
were consumed within 15 minutes and capillary blood samples were collected at 
fasting and 15, 30, 45 and 60 minutes post meal ingestion. All legume treatments 
were found to have a significantly reduced glycemic response in comparison to 
the white bread control meal (P ≤ 0.01). The glycemic response to the chickpea 
meal was the lowest of any legume and was significantly lower than the mung 
beans, black beans and pigeon peas. The chickpea treatment was also found to 
have the lowest GI of any legume (13.87%), followed by white beans (19.48), 
black beans (29.91), pigeon peas (30.99) and mung beans (44.38) (Panlasigui, 
Panlilio & Madrid, 1995). It was assumed that the fat content of the chickpeas 
produced the lowered glycemic effect and that the fiber, amylose and antinutrient 
content of the beans resulted into the lower glycemic response than the control 
meal (Panlasigui et al., 1995). 
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Tappy et al. utilized test meals containing 50 grams of carbohydrate from 
either white kidney bean flakes or a potato flake control meal in six healthy 
subjects and four individuals with T2D (Tappy, Wursch, Randin, Felber & 
Jequier, 1986). Venous blood samples were collected and analyzed for glucose 
and insulin concentrations at fasting and then every 30 minutes for three hours 
posttreatment for the T2D group and over four hours in the healthy participant 
group. Individuals with T2D were instructed not to take their medications prior to 
test days and all meals were consumed within a 20 minute time period. The 
healthy subject group experienced a significantly attenuated increase in both 
glucose (P ≤ 0.01) and insulin (P ≤ 0.001) 30 minutes after bean consumption in 
comparison to control. However, the bean flakes produced an increase in 
postprandial glucose and insulin after 150 minutes posttreatment compared to 
control in this group. In the healthy participants, the average glucose and insulin 
iAUC calculations were also lower for the bean flakes than for the control (P ≤ 
0.02). In the T2D group, the glucose and insulin levels after bean consumption 
were also lower than that for the control, but these values were not statistically 
significant (Tappy et al., 1986). A more gradual increase in glucose and insulin 
was also seen in this group compared to the healthy participants. 
Winham, Hutchins and Melde studied the glycemic and insulinemic 
response to pinto beans, navy beans and black-eyed peas in low dose (~1/2 cup) 
and high dose (~1 cup) amounts compared to a high GI meal containing a bagel 
and orange juice in healthy participants aged 20 to 65 years. The cooked beans 
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were mechanically altered to form a paste which was provided on a bagel with 
mayonnaise and seasonings along with orange juice. Treatments were matched for 
a carbohydrate content of approximately 120 grams. Venous blood samples were 
collected at fasting and at 30, 60, 90 and 120 minutes post meal ingestion and 
subsequently analyzed for glucose and insulin content. Significant differences 
between the control and bean treatment meals were not seen with regard to 
glucose or insulin measures. The authors hypothesized that this lack of 
significance was seen due the destruction of the bean cell walls that occurred 
during treatment preparation (Winham, Hutchins, & Melde, 2007).  
Individual bean types used in the study  
Three beans of the P. vulgaris species were used in this research study  
including pinto beans, black beans and dark red kidney beans. 
Pinto beans 
A number of large scale studies have reported that the most frequently 
consumed bean containing foods include plain pinto beans, refried pinto beans 
and chili containing pinto beans (Mitchell et al., 2009; Lucier et al., 2000). 
Winham, Hutchins and Melde also used pinto beans in a study looking at the 
glycemic and insulinemic responses of three bean types prepared as a spread in 
normoglycemic adults.  A significant difference in the glucose response of study 
participants was not seen, potentially due to the treatment preparation (Winham et 
al., 2007).  
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Black beans 
Black beans are one of the most commonly consumed bean types in the 
United States, especially in the southern areas of the country (Lucier et al., 2000). 
They are also popular within Latin American countries including Brazil, Cuba and 
other areas of South and Central America (Leterme & Munoz, 2002). Black beans 
are often paired with rice in these areas (Kabagambe, Baylin, Ruiz-Narvarez, 
Siles & Campos, 2005). Jang and colleagues (2001) tested a whole grain meal 
containing black bean flour against the participants’ usual diet containing refined 
rice in a group of individuals with coronary artery disease and T2D. They found a 
24% and 14% decrease in fasting glucose and insulin, respectively after the 16 
week whole grain treatment period (Jang et al., 2001).  
Dark red kidney beans 
Dark red kidney beans are also popular bean types within the United 
States (Lucier, 2000). Bornet and colleagues (1987) included kidney beans as one 
of six carbohydrate rich treatments in individuals with T2D. However, it was not 
stated whether these kidney beans were of the red or white variety. The beans 
were provided alone and in mixed meals and venous blood samples were 
collected at fasting and every half hour for a three hour period and analyzed for 
GI, insulinemic index and iAUC for glucose and insulin. The GI of this treatment 
provided alone was found to be the lowest of all six treatments (23) and 
significantly reduced compared to bread (P ≤ 0.001), potatoes (P ≤ 0.01) and 
white rice (P ≤ 0.05).  
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Beans consumed as part of a low glycemic index diet 
A number of studies have included beans as part of a low GI diet. These 
treatments have found such diets to be beneficial with regard to the glucose and 
insulin response to such foods (Brand-Miller, Hayne, Petocz & Colagiuri, 2003; 
Miller, 1994).  
Brand and colleagues assessed the short and long term metabolic effects of 
consuming a low GI diet containing beans, as compared to a similar diet 
containing foods with a high GI using outcome measures including HbA1c, 8 
hour postprandial glucose, fasting glucose levels and lipid profiles (Brand, 
Colagiuri, Crossman, Allen, Roberts & Truswell, 1991). Sixteen subjects with 
non-insulin-dependent T2D were recruited for this randomized crossover study. 
Six subjects managed their glucose levels through diet and the remaining ten used 
oral hypoglycemic agents. The two diets were matched for fiber, carbohydrate, 
protein and fat but differed in their expected GI values by approximately 15% 
(Brand et al., 1991). The researchers found that the low GI diet lowered the 
participants’ HbA1c values by around 11% and that the glucose iAUC was 
significantly lower for the low GI diet in comparison to the high GI diet. 
However, significance was not found for lipid or fasting glucose levels (Brand et 
al., 1991). 
Fontvieille and colleagues looked at the metabolic effects of consuming a 
low GI diet in comparison to a high GI diet over a five week period in 18 diabetic 
individuals (Fontvieille, Rizkalla, Penfornis, Acosta, Bornet & Slama, 1992). This 
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crossover study used 12 individuals with Type 1 diabetes and 6 individuals with 
non-insulin dependent T2D. Participants were fed a low GI and a high GI diet for 
5 weeks each. The low GI diet contained legumes, pasta and rice and the high GI 
diet contained ample amounts of bread and potatoes. HbA1c, body weight and 
medication requirements were not significantly different between diets 
(Fontvieille et al., 1992). However, metabolic parameters including fructosamine, 
fasting glucose levels and postprandial glucose levels two hours after meal 
consumption were significantly lower after consumption of the low GI diet in 
comparison to the high GI diet (P ≤ 0.05, 0.02 and 0.02, respectively). 
Jarvi et al. (1999) conducted a study looking at the glucose and insulin 
concentrations and incremental areas under the curve for glucose and insulin in 
two groups of 10 adults (n = 20) with non-insulin dependent T2D. A low GI diet 
(average of 56.8%) was compared to a high GI diet (average 82.7%) over 
consecutive 24 day periods in an unblended crossover study design. Both diets 
contained a variety of beans (e.g. white beans, red kidney beans and brown beans) 
and utilized 1 week repeated menus over the study period (Jarvi, Karlstrom, 
Granfeldt, Bjorck, Asp & Vessby, 1999). Study participants came to a metabolic 
ward for 2 days at the start and end of each 24 day dietary period. Blood samples 
were obtained at fasting and at 60, 120, 180, 240, 300, 360, 480 and 540 minutes 
afterward. Regular meals adhering to the low or high GI requirements were 
provided. The researchers found that the glucose iAUC following consumption of 
the low GI diet was 31% lower (P ≤ 0.05) than after the high GI diet and that the 
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iAUC for insulin was 27% lower (P ≤ 0.01). Fasting blood glucose levels were 
significantly reduced by approximately 14% following both diet periods (P ≤ 
0.001). Jarvi et al. (1999) concluded that reducing the GI of the diet would be 
useful in management of T2D.  
Rivellese and colleagues (1980) conducted a crossover study looking at 
the glycemic effects of consuming various amounts of fiber in three different 
meals. Study participants include eight individuals with T2D, four of whom were 
using insulin and four who were using diabetes medications. Participants were 
confined to a metabolic ward during the study and consumed each diet for ten 
days. Blood samples were obtained at 0800, 1200, 1400, 1800 and 2000 hours at 
the end of each ten day period. The first diet, A, included 53% carbohydrate and 
16 grams of fiber and was intended to act as a control treatment that replicated the 
standard Italian diet. The second diet, B, contained the same amount of 
carbohydrate but included 54 grams of fiber. This treatment contained 
approximately 45% of dietary fiber from an assortment of beans, peas and lentils. 
A third diet, C, included less carbohydrate than the first two (42%) and a fiber 
content of 20 grams. It was determined that glucose levels two hours after meal 
consumption were significantly lower after the high fiber meal B was consumed 
compared to diets A (P ≤ 0.01) and C (P ≤ 0.05). The glucose average for the 5 
timepoints was also significantly lower (P ≤ 0.05) for the high fiber diet than for 
the control or low carbohydrate diets (Rivellese, Riccardi, Giacoo, Pacioni, 
Genovese, Mattioli & Mancini, 1980). 
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Schafer et al. conducted an acute study to determine the effects of dried 
pea consumption on the glycemia of nine individuals with T2D (Schafer, Schenk, 
Ritzel, Ramadori & Leonhardt, 2003). Participants who were taking medications 
known to affect blood glucose levels such as oral diabetes medications and insulin 
were excluded from the study. A mixed meal containing dried peas was compared 
to two similar meals, one containing potatoes and another with a combination of 
the two foods. All meals were matched for a total carbohydrate content of 36 
grams. The researchers found that postprandial glucose and insulin concentrations 
were significantly lower for the test meal containing peas in comparison to the 
potato meal. Glucose incremental areas under the curve calculations were found 
to be significantly lower for the pea meal than for the potato control (P ≤ 0.01), 
but the insulin iAUC did not hold significance. Schafer and colleagues concluded 
that the consumption of high-fiber, low GI foods such as dried peas should be 
recommended for individuals with T2D to assist in postprandial glucose control 
(Schafer et al., 2003). 
Suitability of Rice as a Reference Food 
A study conducted by researchers in Japan (Sugiyama et al., 2003) looked 
at the GI values of commonly consumed Japanese food items and a comparison of 
a white rice control meal to a glucose challenge to determine if white rice was a 
suitable reference food for GI research studies.  Japanese adults were fed dietary 
treatments (either white rice or white rice and a treatment food) containing 50g of 
carbohydrate.  Capillary blood glucose concentrations were determined and the 
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iAUC for glucose calculated for each treatment in all participants.  The 
correlation between the iAUC values of the two control meals (glucose and white 
rice) was statistically significant at r = 0.853.  Therefore, the researchers 
concluded that a white rice control meal is a useful alternative for use in glycemic 
response studies (Sugiyama et al., 2003). 
The Second Meal Effect 
Many glycemic response studies do not control for the previous evening’s 
meal consumed by their participants. Studies have shown that one’s evening meal 
can help to moderate morning glucose levels (Granfeldt, et al., 2006; Wolever, 
Jenkins, Ocana, Rao & Collier, 1988). Granfeldt and colleagues (2006) assessed 
morning glucose and insulin after consumption of three evening meals, each 
containing 50g of available carbohydrate: barley kernels, spaghetti or a control 
meal containing white bread. Fourteen healthy, normal weight participants were 
included in the study. Capillary blood samples were taken at fasting and 15, 30, 
45, 70, 95, 120 and 180 minutes after consumption of a standardized bread based 
meal. This meal contained 50g of available starch and was consumed within 10 
minutes. The GI and insulinemic index for the spaghetti and barley kernel 
treatments were determined and blood samples were assessed for glucose and 
insulin. IAUC for glucose and insulin was also calculated between 0 and 95 
minutes and 0 and 120 minutes postprandial. The GI and insulinemic index of the 
treatments were found to be 54 and 53 for spaghetti and 53 and 50 for barley 
kernels. Average fasting glucose concentrations were not found to significantly 
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differ between treatments. However, 30 minute postprandial glucose levels and 45 
minute postmeal insulin concentrations following consumption of the evening 
meal containing barley kernels were significantly lower than the other two 
treatments (P ≤ 0.05) (Granfeldt et al., 2006). Postprandial iAUC for glucose 
between 0-95 minutes was also found to be significantly reduced by 23% for the 
barley kernel treatment compared to the spaghetti and white bread. The 
researchers concluded that the composition of the evening meal affected the 
morning glycemic and insulinemic response (Granfeldt et al., 2006).  
Three similar studies were conducted by Wolever and colleagues (1988) to 
test the glycemic results of six separate evening meals in healthy adults. The first 
study compared a high GI meal containing glucose and soybeans against a low GI 
meal including red lentils. Glucose levels were assessed in the morning after a 
breakfast containing glucose was consumed. The second study included meals 
containing whole wheat bread (low GI) or white bread (high GI) in ten healthy 
volunteers. Glucose values were determined after a breakfast containing 
cornflakes and 2% milk was consumed. The third study used mixed meals as 
evening test treatments in a group of six healthy men. The low GI meal consisted 
of glucose, red lentils, barley, peas, cheese and margarine and the high GI meal 
consisted of potato, bread, peas, cheese and margarine. A cornflake and milk 
breakfast was provided. In studies one and two, glucose was assessed using 
capillary blood obtained by fingerstick and analyzed using an YSI glucose 
analyzer. Venous samples were assessed for glucose concentrations in the third 
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study. It was determined that the participants’ morning glucose levels were 
significantly lower after consumption of the low GI meals in comparison to the 
meals with higher GI values. While the aforementioned studies were conducted in 
individuals without T2D, this study will provide standard evening meals to all 
participants. These meals will fits within the participants’ individual diets to avoid 
any variation in morning glucose levels due to potential changes in evening meal 
consumption. 
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CHAPTER 3 
MATERIALS AND METHODS 
Participant Selection 
Adults aged 35-70 years old from the college campus and neighboring 
communities with T2D controlled by metformin or diet/exercise were recruited to 
participate through the use of fliers (Appendix A), newsletters and e-mail 
announcements. Participant eligibility was determined through telephone oral 
interviews or through online screening (www.surveymonkey.com). Persons using 
insulin or other diabetic drugs besides metformin were excluded to minimize 
potential confounding from multiple hypoglycemic medications with various 
modes of action. All participants were physician-diagnosed with T2D at least 6 
months prior to starting the study. The method of diabetes control had to be the 
same for at least 3 months prior to study entry. Eligible participants had an 
HbA1c value of <10% at screening and had no evidence of condition(s) that 
would influence their ability to complete the study as determined from medical 
record analysis. Those with weight changes +/- 5kg within 6 months, women who 
were either pregnant or breastfeeding, and individuals with allergy to beans or 
latex were excluded during the screening process.  
It was determined that a minimum of nineteen (19) diabetic adults was 
needed to test our study hypotheses at a power level of 80% and an error value of 
0.05, as indicated through power analysis (Appendix B). Twenty-eight individuals 
with T2D enrolled in the study. Twenty-one successfully completed the study in 
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its entirety, but four participants were excluded from final analysis. Three of the 
latter participants did not fully disclose medical conditions until after they started 
the study and were ineligible. An additional participant was determined 
noncompliant with the pre-test date dietary protocol during data entry. Data from 
17 individuals (9 men and 8 women) aged 38-70 years were analyzed (Table 1). 
Study Design 
Participants provided written, informed consent prior to their participation 
in the study (Appendix C). A HIPAA Waiver of Authorization (Appendix D) was 
also signed for researcher access to participant medical records, in order to obtain 
information related to diabetes diagnosis, diabetes medication prescription (if 
applicable), weight changes, concurrent disease diagnoses and blood chemistry 
parameters including: blood glucose, insulin, HbA1C and lipid levels. Participant 
medical records were accessed twice: once shortly after the initial screening 
appointment and again 3-6 months after study completion. Medical records access 
was obtained through the use of a participant-signed form faxed directly to their 
primary care physician (Appendix E). This study protocol was approved by the 
ASU Institutional Biosafety Committee of the Office of Research Integrity and 
Assurance, IRB Protocol   0907004180 (Appendix F).  
Subject screening and recruitment occurred on a rolling basis. Screening 
protocol consisted of completion of a medical history screening form (Appendix 
G), general and HIPAA informed consent forms and a brief food screener 
including questions created by the researchers that inquire about bean 
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consumption as well as the Block Fat and Fruit and Vegetable Screeners 
(Appendix H). The 2005 Block FFQ was completed once during the study 
(Appendix I). During the screening appointment, subjects were also trained on 
how to complete the FFQ and the 24-hour dietary records prior to each test day 
(Appendix J).  
Participants who met the screening criteria were given a subject number, 
randomized to a treatment group and scheduled for their first test day. Participants 
were also provided with a packet of information to assist them with study 
compliance. This packet included printed calendars with their scheduled test days, 
detailed participant instructions and researcher contact information; copies of 
their consent forms; and 24-hour dietary record forms. 
Participants were administered four different test meals separated by one 
week as part of this randomized crossover study (clinical trial number: NTS0020). 
At the time of study consent, participants selected a commercial frozen entrée 
meal, e.g. Lean Cuisine or Marie Callender’s, which they consumed for each of 
the four pre-test evening meals. These meals were obtained from local markets 
and meal composition (namely, carbohydrate content) coincided with the 
subjects’ normal dietary intake pattern as determined from pre-study discussion 
with them. Nutrient composition of these meals is provided in Table 2. 
Consuming the same evening meal the night before testing helped to reduce any 
variation in glycemic response due to the second meal effect (Venn & Mann, 
2004; Brand-Miller et al., 2003). The researchers provided the participants with 
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the frozen meal and instructions for completing a 24-hour dietary recall for the 
day before testing. Since alcohol and caffeine can affect blood glucose levels, 
these substances were restricted for 24 hours prior to each test day. Light, 
moderate and heavy physical activity was also limited 24 hours prior to testing to 
prevent exercise-related glycogen depletion (Gropper et al., 2009). 
After consuming the provided meal on the eve of testing, participants 
drank only water until they arrived at the test site 12 hours later. Upon arrival at 
the test site, participants were weighed using a digital scale (Seca Model 880, 
Hamburg, Germany) and confirmed fasting. Standing height was assessed at the 
first test day meeting using a wall-mounted stadiometer (SECA, Ontario, CA). 
Next, a fasting capillary blood sample (~100µl) was collected from a fingerstick 
using Safe-T-Fill
®
 Lithium Heparin Mini Capillary Collection centrifuge tubes 
(RAM Scientific, Yonkers, NY). After the fasting blood sample collection, 
participants consumed one of the four bean/rice test meal options within 5-10 
minutes under researcher supervision. Whole blood glucose concentrations at 
baseline and at 30, 60, 90, 120, 150, and 180 minutes post-treatment were 
analyzed using a Yellow Springs Instrument 2500 Stat Plus Analyzer (YSI Life 
Sciences, Yellow Springs, OH) immediately after blood collection. After all blood 
samples have been collected (approximately 4 hours total), subjects were 
provided a $30 gift card to either Target or Wal-Mart and were given their next 
pre-test meal. Participants who completed the study in its entirety received an 
additional $40 gift card to the above retailers. 
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Test meals 
Participants received the four test meals in random order. Three meals 
included one of the commercially canned P. vulgaris market classes: pinto beans, 
black beans or dark red kidney beans along with ~1/2 cup of white rice. A control 
meal containing 180 grams or approximately 7/8 cup of cooked white rice was 
included as the fourth meal. Enriched long grain white rice was used as part of the 
test meals due to its comparatively high GI value to the beans used and for its 
suitability as a reference food (Sugiyama et al., 2003). Nutrient composition of 
these meals is provided in Table 3. The amount of the beans was standardized to 
provide 50 grams of available carbohydrate. Available carbohydrate was 
calculated by subtracting the dietary fiber from the total carbohydrate value listed 
on the manufacturer’s nutrition facts label (Schakel et. al, 2008; Foster-Powell, 
2002; Asp, 1995). This number coincides with the 45-60g carbohydrate per meal 
recommended by the American Diabetes Association
 
(ADA, 2009). Fifty grams 
of carbohydrate is a standard amount used to test glucose response among persons 
with and without T2D (Bornet et al., 1987; Josse, Kendall, Augustin, Ellis & 
Jenkins, 2007; Panlasigui et al., 1995). White rice was prepared in an electric 
automatic rice cooker (Black & Decker RC400, Miami Lakes, FL). Based on the 
manufacturer’s instructions and using the measuring container provided with the 
rice cooker, the rice and water amounts were standardized for preparation 
consistency. Proportions of 945g of bottled drinking water was added to 420g of 
dry white rice and steamed for around 30 minutes. The canned beans (Bush 
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Brothers & Company) were drained and heated in a microwave for 1 minute at 
medium power. The test meal was prepared by weighing out the cooked rice, then 
adding the appropriate weight of warmed beans, and 15 grams of the drained can 
liquid for moisture. The digital scale was tared to zero after addition of each food 
item (Salter, Fairmont, MN).  
Randomization of dietary treatments 
Participants received a total of four dietary treatments (pinto beans, black 
beans and dark red kidney beans with white rice and a white rice control) spaced a 
minimum of five days apart, as part of a 4x4 randomized block design. Dietary 
treatments (Appendix K) were randomized using the RAND random number 
function in Microsoft Excel (2007). This function produces a random number 
between 0 and 1 and a column including treatments 1 through 4 was sorted by 
these numbers. 
Laboratory analyses 
Screening blood tests including HbA1C, total cholesterol, HDL-
cholesterol, triglyceride as well as LDL-cholesterol calculations were obtained for 
participants lacking these values in their medical records within three months 
previous of their screening date. Blood samples for these tests were analyzed by 
Sonora Quest (Tempe, AZ). HbA1C was determined from a venous whole blood 
sample contained in a lavender top EDTA tube. The blood sample was then 
analyzed through photometric assay. Lipid values were assessed using whole 
blood samples collected in a red top Vacutainer
 
serum barrier tube. Total 
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cholesterol and triglyceride values were determined through photometric assay. 
HDL cholesterol levels were determined through homogenous enzyme 
immunoassay (Sonora Quest, Tempe, AZ). 
Capillary blood samples were collected by a trained graduate student using 
Safe-T-Fill
®
 Lithium Heparin Mini Capillary Collection 125µl centrifuge tubes 
(RAM Scientific, Yonkers, NY). Whole blood samples were analyzed for glucose 
content using the Yellow Springs Instrument Stat Plus Analyzer (YSI Life 
Sciences, Yellow Springs, OH) immediately after blood collection. This 
instrument can evaluate glucose concentrations up to 900mg/dL using an 
Immobilized Enzyme Biosensor (Appendix L). Glucose levels are determined 
through the following process: the sample is treated with the enzyme glucose 
oxidase, the enzyme becomes immobilized between two membranes and is 
oxidized to form D glucono-δ-lactone and hydrogen peroxide. The hydrogen 
peroxide is then filtered through the second membrane and oxidized by a platinum 
electrode. The electrical current produced by the oxidization reaction is 
proportional to the glucose concentration of the sample.  
Statistical analyses 
The SPSS Statistics software version 19.0 (IBM Corporation, Somers, 
NY) was used for statistical analyses. The Food Processor SQL (ESHA Research, 
Salem, OR) was used for analysis of the 24-hour dietary recall data and the Block 
dietary screeners for fat and fruit and vegetable intake were analyzed online via 
the NutritionQuest website (www.nutritionquest.com). The level of significance 
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was P ≤ 0.05. Time point differences between fasting and post-treatment glucose 
concentrations were determined and iAUC calculations were completed using the 
trapezoidal rule (Table 4) (Sheng, Lefebvre, Fastenau, Tak Piech & Waltzman, 
2005). Incremental areas under the curve for blood glucose were assessed 
between 0-60, 0-120, and 0-180 minutes postprandial for all participants. Effect 
size, or the “substantive significance” of the treatments were calculated and 
assessed using Cohen’s (1988) interpretation (Hill, Bloom, Black & Lipsey, 
2008). As part of this interpretation, a small effect size ranges from 0.20 to 0.50, a 
medium effect is between 0.50 and 0.80 and a large effect size is a value ≥0.80. 
Multiple analysis of variance (MANOVA) for repeated measures with time and 
diet as factors was used to establish differences between the four meal treatments. 
Following a significant MANOVA, paired t tests were used to identify differences 
between specific bean treatments and the rice control. Independent t tests were 
also used to analyze differences by gender and treatment type. Continuous 
variable data are reported as mean ± standard error. 
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TABLE 1. Baseline characteristics of study participants (n = 17) 
Variable  Mean ± SEM Range 
Age (y) 58.6 ± 2.3 (38-70) 
Race/Ethnicity: n, (%) 
     Non-Hispanic 
     White 
     Other 
 
16 (94%) 
14 (82%) 
3 (18%) 
 
Weight (kg)
1 
93.4 ± 4.0 (67.8-120.9) 
Height (cm)
1 
170.7 ± 2.1  (154.4-184.5) 
BMI (kg/m
2
)
1 
31.9 ± 1.0 (26.9-38.8) 
TC (mg/dL)
 
172.9 ± 7.5 (119.0-220.0) 
TG (mg/dL)  156.4 ± 18.8 (68.0-328.0) 
HDL-C (mg/dL) 44.4 ± 1.9 (36.0-65.0) 
LDL-C (mg/dL) 98.9 ± 5.6 (59.0-133.0) 
HbA1c (%) 6.5 ± 0.1 (5.8-7.8) 
1 
Values obtained at study entry. BMI = body mass index, TC = total cholesterol, 
TG = triglycerides, HDL-C = high density lipoprotein cholesterol, LDL-C = low 
density lipoprotein cholesterol, HbA1c = hemoglobin A1c 
 
 
TABLE 2. Macronutrient composition of evening meals consumed 
prior to test days
1
 
Characteristics Value Range 
Energy (kcal) 517.4 ± 29.0 (300.0-710.0) 
Total fat (g) 24.8 ± 3.1 (9.0-43.0) 
Saturated fat (g) 10.6 ± 1.6 (2.0-17.0) 
Cholesterol (mg) 118.4 ± 16.3 (25.0-205.1) 
Carbohydrate (g) 39.6 ± 2.5 (26.0-53.0) 
Total fiber (g) 5.7 ± 0.5 (3.0-11.0) 
Protein (g) 33.6 ± 2.0 (13.0-44.0) 
1 
All values are means ± standard error of the mean (SEM) (range) 
kcal =kilocalorie, mg=milligram, g=gram 
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TABLE 3. Descriptive characteristics of test meals
1 
Characteristics 
White 
Rice 
Control 
Pinto 
Beans/ 
Rice 
Black 
Beans/   
Rice 
Kidney 
Beans/   
Rice 
Total weight (g) 
     Rice (g) 
     Beans (g) 
180.0 
180.0 
--- 
305.0 
128.0 
177.0 
243.0 
128.0 
115.0 
267.0 
128.0 
139.0 
Energy (kcal) 232.0 273.9 257.9 277.2 
Total carbohydrate (g) 49.5 59.7 55.5 58.7 
Available CHO (g) 48.8 49.7 49.7 49.7 
     Rice (g) 
     Beans (g) 
Fiber (g) 
48.8 
--- 
0.7 
34.7 
15.0 
10.0 
34.7 
15.0 
5.8 
34.7 
15.0 
9.1 
Protein (g) 4.8 11.6 9.6 10.9 
Fat (g) 0.5 0.4 0.8 0.4 
1 
All values are means ± standard error of the mean (SEM) (range). 
kcal = kilocalorie, mg = milligram, g = gram 
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CHAPTER 4 
           RESULTS 
Descriptive statistics at study entry for the 17 participants are shown in 
Table 1. A majority of the participants were White (82%) and non-Hispanic 
(94%). Participants were also, on average, considered to be obese according to 
their BMI values (31.8 ± 1.0 kg/m
2
). Fourteen participants used the medication 
metformin to manage their T2D and the remaining three used dietary methods 
and/or physical activity. Data were analyzed by gender and treatment type prior to 
analysis of the pooled data. Body weight and BMI were not found to significantly 
differ between test days. No significant differences were seen between those in 
the diet/physical activity group (n = 3) and those taking metformin (n = 14) with 
regard to descriptive statistics, time point glucose differences or iAUC values. 
However, there may not have been adequate power to detect such differences due 
to small sample size.  
Some differences were seen between gender groups with regard to 
descriptive characteristics, timepoint glucose differences and iAUC values. As 
expected, body mass and height were significantly higher for the men (P = 0.012 
and P = 0.000, respectively) than for the women. Conversely, total cholesterol 
was found to be lower in the men than women (155.8 ± 9.7 versus 192.3 ± 7.3, P 
= 0.010). Significance was also seen between gender groups for a few timepoint 
glucose differences (Table 4). These significant differences occurred at 30 
minutes for the black bean and rice treatment (P = 0.012) and at 60 minutes for 
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the control meal and black bean and rice meal (P = 0.036 and P = 0.023, 
respectively). In all cases, the men were found to have lower values than the 
women. With regard to glucose iAUC, the male participants were also found to 
have lower values than the female participants for the black bean and rice 
treatments between 0-60 minutes as well as 0-120 minutes (P = 0.006 and P = 
0.038, respectively) (Table 5). 
When participant data were pooled, time point glucose differences (Table 
6, Figure 1) were found to be significantly lower at 90 minutes postprandial for 
the pinto beans and rice (P = 0.011), black beans and rice (P = 0.004), and dark 
red kidney beans and rice (P = 0.040) compared with the white rice control meal. 
Similar results were seen at 120 minutes (P = 0.000, 0.001 and 0.026 for the pinto 
beans, black beans, and dark red kidney beans respectively) and 150 minutes 
postprandial (P = 0.000, 0.002, and 0.0049). The black beans and rice meal was 
also found to be significantly lower than control at the 180 minute time point (P = 
0.015). The 90 minute difference had an effect size of 0.469 (small, power = 
0.729), meaning that approximately 47% of glucose measures at this time point 
were affected by bean consumption. The effect sizes were larger at the 120 and 
150 minute glucose time points with eta
2 
values of 0.634 (medium, power = 
0.960) and 0.554 (medium, power = 0.873), respectively.  
Incremental areas under the curve for blood glucose were assessed 
between 0-60, 0-120 and 0-180 minutes postprandial for all participants (Table 7, 
Figure 2). Significant differences were found between the control meal and the 
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pinto beans and rice and black beans and rice at 0-120 (P = 0.009 and 0.002) and 
0-180 minutes (P = 0.017 and 0.007). Effect sizes via repeated measures ANOVA 
were found to be 0.431 (small, power = 0.656) and 0.501 (small, power = 0.787) 
for the iAUC at 120 and 180 minutes, respectively. 
The participants’ evening meal choices and 24-hour dietary recalls were 
analyzed for macronutrient content using the Food Processor SQL (EHSA 
Research, Salem, OR) (Table 8). Carbohydrate intake was found to be 
significantly higher during the pre-pinto beans and rice days as compared to the 
other treatments (P = 0.032). However, no other macronutrients during these pre-
test days were found to differ significantly from one another.  
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TABLE 4. Mean ± SEM incremental changes in blood glucose for all treatments 
by gender
1
 
 
 
White Rice 
Control 
Pinto beans 
and white rice 
Black beans 
and white rice 
Kidney beans 
and white rice 
Men (n = 9)     
Fasting glucose 
(mg/dL) 
96.2 ± 5.2 100.1 ± 4.7 101.8 ± 4.5 96.8 ± 4.3 
30 min glucose 
(mg/dL) 
49.4 ± 2.9 42.5 ± 5.7 42.4 ± 4.1* 51.3 ± 6.0 
60 min glucose 
(mg/dL) 
64.7 ± 5.4* 62.3 ± 7.0 59.9 ± 5.9* 67.6 ± 7.6 
90 min glucose 
(mg/dL) 
53.3 ± 6.7 41.9 ± 9.9 41.4 ± 7.3 45.1 ± 7.4 
120 min glucose 
(mg/dL) 
32.0 ± 5.3 14.8 ± 8.5
 
18.3 ± 7.4
 
25.8 ± 7.7 
150 min glucose 
(mg/dL) 
14.7 ± 6.1 2.6 ± 5.4
 
4.0 ± 6.3
 
9.7 ± 6.5 
180 min glucose 
(mg/dL) 
-0.0 ± 6.9 -5.7 ± 3.1 -8.9 ± 5.5 -2.2 ± 4.9 
Women (n = 8)     
Fasting glucose 
(mg/dL) 
102.4 ± 7.4 
 
106.5 ± 5.1 
 
102.1 ± 7.1 
 
103.7 ± 7.5 
 
30 min glucose 
(mg/dL) 
60.8 ± 7.4 
 
55.4 ± 7.3 
 
63.5 ± 6.4 
 
56.0 ± 8.0 
 
60 min glucose 
(mg/dL) 
85.2 ± 7.3 
 
77.9 ± 8.3 
 
79.1 ± 4.4 
 
78.5 ± 6.1 
 
90 min glucose 
(mg/dL) 
69.3 ± 9.0 
 
50.7 ± 5.4 
 
53.0 ± 6.0 
 
57.3 ± 6.9 
 
120 min glucose 
(mg/dL) 
42.3 ± 8.0 
 
23.6 ± 5.9 
 
25.5 ± 6.3 
 
31.9 ± 5.6 
 
150 min glucose 
(mg/dL) 
20.1 ± 6.8 
 
6.1 ± 3.8 
 
4.9 ± 4.2 
 
10.3 ± 5.0 
 
180 min glucose 
(mg/dL) 
1.6 ± 5.4 
 
-5.0 ± 3.6 
 
-7.9 ± 5.0 
 
-3.3 ± 4.0 
 
1
 All values are means ± standard error of the mean.
 
* P <0.05, ** P <0.01, *** P <0.001 
Min=minutes, mg/dL=milligrams per deciliter 
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TABLE 5. Postprandial areas under the curve for blood glucose by gender
1, 2, 3 
 
 
White Rice 
Control 
Pinto beans 
and white 
rice 
Black beans 
and white 
rice 
Kidney beans 
and white rice 
Men (n = 9)     
0-60 min 2461.1 ± 
119.6 
2225.3 ± 
216.0 
2160.8 ± 
159.8** 
2552.4 ± 
270.8 
0-120 min 5505.9 ± 
422.5 
4690.7 ± 
589.7 
4587.4 ± 
495.8*
 
5319.4 ± 
635.5 
0-180 min 6575.2 ± 
653.1 
5191.5 ± 
755.9
 
5198.9 ± 
684.8
 
6208.8 ± 
860.3 
Women (n = 8)     
0-60 min 3103.0 ± 
301.5 
2829.2 ± 
323.7 
3089.8 ± 
249.9 
2855.5 ± 
300.5 
0-120 min 7095.6 ± 
744.6 
5871.1 ± 
513.5 
6248.6 ± 
538.8 
6231.5 ± 
524.5 
0-180 min 8406.2 ± 
1038.9 
6462.1 ± 
550.7 
6883.4 ± 
670.2 
7094.1 ± 
614.3 
1
 All values are means ± standard error of the mean. 
2 
Mg * min/dL (calculated by 
the trapezoidal rule). 
3
For variables in which the treatment x AUC interaction was 
significant, paired t tests were conducted to assess within-group change.  
* P <0.05, ** P <0.01, *** P <0.001 
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TABLE 6. Incremental changes in blood glucose for all treatments (n = 17)
1,2  
 
Glucose 
Concentrations 
(mg/dL)
2 
White rice 
Control 
Pinto beans 
and white rice 
Black beans 
and white rice 
Kidney beans 
and white rice 
Baseline  99.1 ± 4.4 103.1 ± 3.4 101.9 ± 3.9 100.1 ± 4.1 
30 min  54.8 ± 4.0 48.6 ± 4.7 52.3 ± 4.4 53.5 ± 4.8 
60 min  74.3 ± 5.0 69.6 ± 5.5 68.9 ± 4.4 72.7 ± 5.0 
90 min  60.8 ± 5.7 46.0 ± 5.8*
 
46.9 ± 4.9**
 
50.9 ± 5.2*
 
120 min  36.8 ± 4.7 18.9 ± 5.2***
 
21.7 ± 4.8**
 
28.7 ± 4.8*
 
150 min 17.3 ± 4.5 4.2 ± 3.3*** 4.4 ± 3.8** 10.0 ± 4.0*
 
180 min 0.8 ± 4.3 -5.4 ± 2.3 -8.4 ± 3.6*
 
-2.7 ± 3.1 
1 
All values are means ± standard error of the mean (SEM).
 
2 
Incremental change refers to glucose at timepoint x – glucose at baseline  
* P <0.05, ** P <0.01, *** P <0.001 
Min=minutes, mg/dL=milligrams per deciliter 
 
TABLE 7. Postprandial areas under the curve for blood glucose (n=17)
1, 2,3
 
 
 
White rice 
control 
Pinto beans and 
white rice 
Black beans and 
white rice 
Kidney beans 
and white rice 
0-60 
min 2763.2 ± 170.0 2509.5 ± 199.0 2598.0 ± 181.8 2695.1 ± 199.0 
0-120 
min 6254.0 ± 448.0 5246.2 ± 409.9** 5369.2 ± 409.6*
 
5748.6 ± 420.1 
0-180 
min 7436.8 ± 622.4 5789.4 ± 488.7** 5991.6 ± 510.7** 6625.4 ± 534.6 
1
 All values are means ± standard error of the mean (SEM).  
2 
Mg * min/dL (calculated by the trapezoidal rule) 
3
 For variables in which the treatment x AUC interaction was significant, paired t 
tests were conducted to assess within-group change.  
* P <0.05, ** P <0.01, *** P <0.001 
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TABLE 8. Macronutrient composition of dietary intake 24 hours prior to test days 
(n=17)
1
  
Nutrient 
White rice 
control 
Pinto beans and 
white rice 
Black beans and 
white rice 
Kidney beans 
and white rice 
Energy (kcal) 1736.8 ± 135.6 
(992.4-3114.7) 
1840.5 ± 149.5 
(1042.8-3243.4) 
1560.1 ± 76.1 
(1067.3-2292.7) 
1611.3 ± 114.0 
(1000.9-2529.0) 
 
Total fat (g) 
 
78.5 ± 7.9 
(30.9-158.9) 
 
73.2 ± 8.2 
(33.5-148.0) 
 
65.2 ± 4.7 
(40.6-101.4) 
 
68.9 ± 6.7 
(21.1-128.5) 
 
Saturated fat (g) 
 
24.6 ± 2.3 
(6.4-47.4) 
 
25.2 ± 3.5 
(6.9-62.4) 
 
22.6 ± 2.0 
(9.4-40.6) 
 
24.8 ± 3.4 
(5.9-60.1) 
 
Cholesterol (mg) 
 
271.6 ± 38.5 
(102.7-693.5) 
 
239.0 ± 32.9 
(90.0-553.4) 
 
293.6 ± 50.7 
(97.7-749.8) 
 
254.6 ± 33.6 
(109.2-527.0) 
 
Sodium (mg) 
 
3619.1 ± 215.9 
(2135.4-5465.3) 
 
3958.1 ± 288.3 
(2543.7-6762.9) 
 
3542.7 ± 223.3 
(2307.2-5482.5) 
 
3612.2 ± 298.5 
(1786.5-5835.3) 
 
Potassium (mg) 
 
1071.2 ± 131.8 
(309.7-2375.4) 
 
964.8 ± 133.5 
(238.6-2084.4) 
 
1039.7 ± 104.7 
(341.3-1973.3) 
 
1062.6 ± 142.9 
(338.0-2737.9) 
 
Carbohydrate 
(g)* 
 
174.8 ± 16.6*
 
(77.5-328.8) 
 
212.0 ± 22.9 
(112.9-415.3) 
 
162.4 ± 14.4**
 
(67.6-273.2) 
 
166.0 ± 18.9**
 
(48.2-354.6) 
 
Total fiber (g) 
 
20.6 ± 1.2 
(14.7-28.0) 
 
20.1 ± 1.8 
(6.2-34.0) 
 
20.1 ± 1.7 
(9.6-34.9) 
 
19.2 ± 1.7 
(10.9-36.4) 
 
Protein (g) 
 
88.7 ± 6.4 
(55.8-168.8) 
 
91.3 ± 4.8 
(58.0-124.4) 
 
88.1 ± 4.6 
(59.8-121.4) 
 
86.4 ± 4.8 
(55.5-122.7) 
1 
All values are means ± standard error of the mean (SEM) (range) 
* P <0.05, ** P <0.01, *** P <0.001 
kcal =kilocalorie, mg=milligram, g=gram 
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FIGURE  1.  Influence of treatments on postprandial net glucose (n 
=17)
1
.
 
1
 All values are means ± standard error of the mean (SEM).
 
* P <0.05, ** P <0.01, *** P <0.001 
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FIGURE  2.  Incremental area under the curve differences in net glucose (n = 
17).
1,2 
 
1
 All values are means ± standard error of the mean (SEM). 
2 
Mg * min/dL 
(calculated by the trapezoidal rule) 
* P <0.05, ** P <0.01 
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CHAPTER 5 
DISCUSSION AND CONCLUSION 
This study found that bean and rice meals produce an attenuated glucose 
response in comparison to rice alone in equal available carbohydrate treatments. 
These results reinforce previous studies that show intermediate responses with 
mixed meals of high and low GI foods. These lower responses are favorable to the 
higher response produced by white rice alone, and can help prevent the 
detrimental effects of extended glycemic elevations. Prolonged elevated glucose 
levels contribute to the well-known macrovascular (cardiovascular disease and 
peripheral vascular disease) and microvascular (nephropathy, retinopathy and 
neuropathy) complications associated with T2D. Attenuating postprandial glucose 
changes by encouraging people with T2D to combine beans with a high GI food 
like rice can contribute to a lower risk for the complications associated with T2D. 
Also worthy of note is that all study treatments reduced the 2 hour postprandial 
glucose below 140 mg/dL, which is a goal value recommended by the 
International Diabetes Federation (Ceriello, Colagiuri, Gerich, Tuomilehto, 2008). 
 
P. vulgaris beans such as those included in this study (pinto, black and 
dark red kidney beans) along with white rice is a traditional food combination 
consumed by many in the U.S. and around the world, particularly those in Latin 
America and countries within the Mediterranean and Middle East. Jimenez-Cruz 
and colleagues found that traditional Mexican foods like corn tortillas and pinto 
beans had a low GI, were satiating, and improved glycemic control in T2D adults 
68 
(Jimenez-Cruz et al., 2006). As this study demonstrates, the exclusion of cultural 
foods like the rice/bean combination may be unwarranted for persons with T2D.  
On the contrary, retention of traditional dietary patterns including beans may be 
beneficial to health, reduce T2D complications, and improve dietary adherence 
(Caban, Walker, Sanchez & Mera, 2008; Leterme, 2002; Jimenez-Cruz et al., 
2006).
  
An e-mail survey of Canadian dietitians found that 68% of those surveyed 
stated that they recommend legume consumption to individuals with diabetes, in 
comparison to the 87% who recommended legumes to individuals with known 
cardiovascular disease (Desrochers & Brauer, 2001).
 
The American Diabetes 
Association recommends taking “into account personal and cultural preferences” 
as a goal for T2D Medical Nutrition Therapy (ADA, 2008).
 
However, it is not 
clear in the published scientific literature that culturally appropriate foods such as 
legumes are being recommended to individuals with diabetes in accordance with 
this goal.  
The three P. vulgaris market classes exhibited different levels of glucose 
response. The pinto and black bean/rice combinations produced a lower glycemic 
response overall than the dark red kidney bean/rice meal despite the black beans 
lower total fiber content and the treatments being matched on available 
carbohydrate content. Differences in the specific fiber fractions of the three bean 
types may offer an explanation for the variation in glycemic response produced. 
There is some evidence that beans from the Andean center of domestication may 
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have lower levels of indigestible starch in comparison to beans with 
Mesoamerican origins like pinto and black. Lower levels of indigestible starch in  
kidney beans, therefore, would increase the rate of digestion relative to the other 
bean types (Ospina, 2000).  
Phytochemicals and phytonutrients are associated with improvements in 
glycemic control (Sievenpiper et al., 2009). These characteristics in the beans are 
likely to vary, as well. In general, beans have high levels of phytate which may 
bind to calcium thus reducing it as a cofactor for amylase enzyme activity (Josse 
et al., 2007). Inhibition of alpha amylase by cooked P. vulgaris beans has 
approximated that of acarbose, a popular diabetes medication (Helmstadter, 
2010). Sievenpiper et al. (2009) reported in a meta-analysis that long term use of 
some beans normalized HbA1c almost as well as acarbose in two other meta-
analysis reports.
 
Uncooked pinto beans were found to have higher levels of 
flavonoids than some other beans, and the sum of phenolic acids in the pinto 
beans was greater than chickpeas, split peas, lentils and a variety of broad beans 
(Kalogeropoulos, Chiou, Ioannou, Karathanos & Hassapidou, 2010). Data on 
black or red kidney beans were not reported.   Pinto beans also reportedly contain 
high concentrations of antioxidants in comparison to chickpeas and other non 
P.vulgaris species (Halvorsen et al., 2002). The observed differences in effect of 
the three beans highlights the importance of investigating multiple bean varieties 
rather than assuming all are the same. Further mechanistic work is needed on 
these specific varieties as well.
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  This study demonstrates that culturally relevant P. vulgaris species such as 
pinto, dark red kidney and black beans attenuate the glycemic response to rice, a 
commonly consumed high GI food. As healthcare practitioners, it is vital that we 
are culturally competent and sensitive to the needs of others who are different 
from us. Cultural competency is the “ability to discover the culture of each 
client/patient and effectively adapt interventions to her or him” (Curry, 2000). 
Dietary recommendations, materials and counseling should be culturally sensitive 
and take into account valued traditional foods such as beans, especially when the 
scientific evidence supports their beneficial role in the diet.  
Further research should be completed regarding the physical and chemical 
structure of various P. vulgaris bean types to attempt to address the observed 
differences in glycemic responses.  While promoting traditional foods is a non-
medical way to manage T2D, knowing which beans are most effective can help 
improve dietary adherence with an appropriate cultural twist.  
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Sample Size Calculations 
For 80 % (β = 0.20) power, α = 0.05 
 
 
 
Change in glucose (mg/dL) at 30 minutes from fasting values 
N = [2.8 * 11.9 / 9.0]
2 
= 11.71 = 12 
N = [2.8 * 11.4 / 9.0]
2 
= 12.58 = 13 
Change in glucose (mg/dL) at 60 minutes from fasting values 
N = [2.8 * 17.9 / 15.0]
2 
= 11.16 = 11 
N = [2.8 * 28.5 / 15.0]
2 
= 28.30 = 28 
Average = 16 x 1.2 = 19.2 = at least 19 participants needed to account for 20% 
attrition 
 
Sample size calculation data obtained from Johnson et al (2005) (n = 11 healthy 
adults) and Johnston et al (2004) (n = 10 individuals with type 2 diabetes)  
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CONSENT FORM 
EFFECT OF PINTO, BLACK AND DARK RED KIDNEY BEAN 
CONSUMPTION  
AS PART OF A MEAL ON POSTPRANDIAL GLUCOSE 
IN ADULTS WITH TYPE 2 DIABETES 
 
Introduction 
Dr. Donna Winham, Assistant Professor, Department of Nutrition has invited 
your participation in a research study. The purpose of this form is to provide you 
information that may affect your decision as to whether or not to participate in 
this research, and to record the consent of those who agree to be involved in the 
study. 
 
Study Purpose 
The purpose of the research is to determine the effect of different types of beans 
(pinto beans, black beans, dark red kidney beans) and rice on how much blood 
sugar rises after a meal. This is also known as the glycemic response. The study 
will also look at other blood biomarkers of chronic disease (i.e. lipids, insulin, 
antioxidants, vitamins, minerals). 
 
Description of the Research Study 
If you decide to participate, you will join a study that looks at the effects of eating 
beans on blood glucose levels in the blood. Your participation will initially 
involve going to the test site (the Nutrition Program at Arizona State University at 
the Polytechnic Campus) to complete a questionnaire about your recent food 
intake and a medical history screener in order to assess your health and diet status. 
Your signature on a separate HIPAA form will allow access to your medical 
records in order to obtain measures of your body weight and blood chemistry 
values including: blood glucose, insulin, HbA1c and cholesterol levels for a 
maximum period of 1 year before and up to 1 year after the study period. To 
access these records, a separate release of medical records form, signed by you, 
will be sent to your primary care physician. With your permission, we will access 
your medical records 2 times – once shortly after you enroll in the study, and a 2nd 
time 6-8 months after you complete the study. If you have not had a lipid panel or 
HbA1c test as part of your regular medical treatment within 30 days of your study 
enrollment, we will measure these as part of the study. An additional amount of 
blood will be taken while you are fasting on the 2
nd
 or 3
rd
 test date. Alternatively, 
you may be given a requisition order for these tests to be performed at Sonora 
Quest laboratories. All laboratory testing costs will be at the expense of the study.   
 
Then, you agree to fast overnight for 12 hours (no food or drink with the 
exception of water) and report to the test site the following morning or scheduled 
day to provide a fasting blood sample to assess your blood glucose and 
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cholesterol concentrations. Your blood pressure along with measurements of 
height, weight and hip circumference will also be assessed on this day.  
 
If you meet the health assessment criteria, and you agree to follow the 
experimental protocol, you will be eligible to participate in the study. The 
experimental protocol includes consuming a test meal (½ cup white rice + either 
½ c of pinto beans, black beans or dark red kidney beans or approximately 7/8 
cup of white rice) on each of the 4 test mornings. You will also record all foods 
and beverages consumed for the 24 hours prior to each test day, using a form 
provided by the researchers. 
 
 
At the beginning of the study and on each testing day, your body weight and 
blood pressure will be recorded. An interviewer will also discuss your food intake 
records for the previous day at this time. These procedures will take around 30 
minutes to complete. Finger stick blood samples will be collected while you are 
fasting, 30 minutes after you have finished the test meal, and then every half hour 
thereafter for a 3 hour period (0, 30, 60, 90, 120, 150, 180 minutes or 7 finger 
stick blood samples total). The time required to complete the experimental 
protocol on each of the testing days will be ~ 4 hours from start to finish. This 
includes 30 minutes for the above measurements and ~3.5 hours for the meal and 
blood draws. You must remain in the vicinity of the study site during this time. 
 
You will consume a meal paid for by the investigators approximately 12 hours 
prior to each testing day. This meal will consist of a frozen prepared meal. The 
same meal selections will be consumed for the 4 pre-test evenings. You will then 
fast for 12 hours prior to each testing day in that you will not consume any food 
or beverage with the exception of water after 7 pm on the night prior to a testing 
day. During the final testing day you will complete a final diet questionnaire. 
Blood (identified only by your participant number) will be analyzed at the 
conclusion of each test day within the ASU Nutrition Department; what remains 
of the blood samples will be destroyed within 2 years of the completion of the 
study. Approximately 25 participants will be participating in this study and your 
testing times may overlap. 
 
You will complete a Food Frequency Questionnaire, a questionnaire related to 
legume intake and a separate screener inquiring about your thoughts related to 
diabetes during screening. This will allow the researchers to determine the quality 
of your diet, your knowledge of beans and your feelings about diabetes. The 
questionnaires will also be mailed to you at the 3 months after you have 
completed the study to assess any changes. 
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One-on-one nutrition counseling will be provided to you after you have 
completed all 4 test days. You will receive a packet containing your blood values, 
dietary intake information and blood glucose responses to each test meals. 
Nutrition education sessions will be offered at the test site on various days 
following completion of the study. The sessions will include information about 
beans, how to include beans in a diabetic diet, a cooking demonstration and a 
variety of informative items to take home with you. These sessions are optional, 
although you and your adult family members are welcome to attend.  
 
Risks 
A trained graduate student will perform the capillary finger sticks for glucose 
analysis under standard and sterile conditions. Temporary bruising of the skin, a 
feeling of faintness, and/or a small degree of discomfort or pain are possible. As 
with any research, there is some possibility that you may be subject to risks that 
have not yet been identified, in addition to the potential risks associated with the 
blood draws as listed above. 
 
Benefits 
You understand that the possible benefits of your participation in the research 
include providing information helpful in the understanding of how bean 
consumption as part of a meal impacts the glycemic response to the meal. In 
addition, you will receive information about your dietary intake, cholesterol status 
and glucose responses to the test foods.  
 
Confidentiality 
All information obtained in this study is strictly confidential unless disclosure is 
required by law. The results of the research study may be published and used in 
presentations or reports, but the researchers will not identify you. In order to 
maintain confidentiality of your records, the investigators will use participant 
codes on all data collected, including the blood obtained during the blood draws, 
maintain an emergency contact list and a master list separate and secure from all 
data collected, and limit access to the confidential information to the principal 
investigators in the study. The signed informed consents will be kept in a locked 
cabinet in Dr. Winham’s office.  
 
Withdrawal Privilege 
It is ok for you to say no. Even if you agree to participate now, you are free to say 
no later, and withdraw from the study at any time. Nonparticipation or withdrawal 
from the study will not affect your relationships with ASU in any way.  
 
Costs and Payments 
The researchers want your decision about participating in the study to be 
absolutely voluntary. Yet they recognize that your participation may pose some 
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costs and inconvenience. In order to help defray your costs and compensate you 
for your incontinence, you will receive a $30 gift certificate to a major retailer 
(Target, Walmart, Home Depot) for each testing day of the study that you 
complete. If you are compliant with the research protocol and complete all four 
study days, you will receive an extra $40 for a total of $160.  
 
Compensation for Illness and Injury 
If you agree to participate in the study, then your consent does not waive any of 
your legal rights. However, in the event of (harm, injury, illness) arising from this 
study neither Arizona State University nor the researchers are able to give you 
any money, insurance coverage, free medical care, or any compensation for such 
injury. 
 
Voluntary Consent 
Any questions you have concerning the research study or your participation in the 
study, before or after your consent, will be answered by Dr. Donna Winham (480-
727-1722). If you have any questions about your rights as a subject/participant in 
this research, or if you feel you have been placed at risk, you can contact the 
Chair of the Human Subjects Institutional Review Board, through the ASU 
Research Compliance Office, at (480) 965-6788. 
 
This form explains the nature, demands, benefits and any risk of the project. By 
signing this form, you agree knowingly to assume any risks involved. Remember, 
your participation is voluntary. You may choose not to participate or to withdraw 
your consent and discontinue participation at any time without penalty or loss of 
benefit. In signing this consent form, you are not waiving any legal claims, rights 
or remedies. A copy of this consent form will be given to you. Your signature 
below indicates that you consent to participate in the above study. 
 
 
________________________    _________________________      ____________ 
  SUBJECT’S SIGNATURE           PRINTED NAME                          DATE 
 
Investigator’s Statement: "I certify that I have explained to the above individual 
the nature and purpose, the potential benefits and possible risks associated with 
participation in this research study, have answered any questions that have been 
raised, and have witnessed the above signature. These elements of Informed 
Consent conform to the Assurance given by Arizona State University to the 
Office for Human Research Protections to protect the rights of human subjects. I 
have provided the participant a copy of this signed consent document." 
 
______________________________                         ____________________ 
SIGNATURE OF INVESTIGATOR                                 DATE 
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HIPAA AUTHORIZATION FORM  
 
Protocol Title: Effect of pinto, black and dark red kidney bean consumption 
on postprandial glucose and insulin in adults with T2DM  
ASU HS # 07-12002492  
Principal Investigator: Donna M. Winham, DrPH 
 
AUTHORIZATION TO COLLECT, USE, AND SHARE HEALTH  
INFORMATION FOR RESEARCH  
 
By law, researchers must protect the privacy of health information about you. 
This form and the attached research consent form need to be kept together.  
We are asking you to take part in the research described in the attached consent 
form. The researchers are not authorized to collect any health information about 
you unless that information is described in the consent form that you sign.  
What is “health information”?  
As used in this form, the phrase “health information” includes: 
 Health information that identifies you. 
 Information in your medical records that is needed for this research study. 
These might include the results of physical exams, blood tests, x-rays, 
diagnostic and medical procedures and your medical history. We will 
access records two times over the course of the study. This refers to the 
future and previous 6 months from the time you start the study. 
 
The specific information that will be collected in this research is described in the 
attached consent form. For you to be in this research, we need your permission to 
collect and share this information. 
Who will see the health information collected in this research?  
If you agree to participate, you are giving permission for the researchers to share 
your health information with the following people and groups: 
 Anyone listed in the informed consent document as a person or group that 
you agree may receive information about you (Dr. Donna Winham and 
Sharon Thompson, BS) 
 Anyone listed in a separate authorization for release of medical records or 
information that is signed by you. 
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 Government agencies, review boards, and others who watch over the 
safety, effectiveness, and conduct of the research. 
 Other researchers when a review board approves the sharing of the health 
information. 
 Others, if the law requires.  
The researchers cannot control what any of these persons or groups may do with 
the information they receive about you and the privacy of your information may 
no longer be protected by federal privacy rules after it is disclosed to them. 
What if you do not want to participate in the research? 
You do not have to sign this permission (“authorization”) form if you do not want 
your medical records released for this research. If you do not sign, then you will 
not be allowed to participate in the study. If you decide not to sign, it will not 
result in any penalty or loss of benefits to which you are entitled.  
If you sign this form and then change your mind later, and do not want us to use 
and share your health information, you will need to send a letter to the researcher 
at the address listed on the attached consent form. The letter will need to say that 
you have changed your mind and do not want the ASU researcher to collect and 
share your health information. The researcher may still use the information they 
have already collected.  
Will you get to see the health information collected about you? 
Depending on the nature of the research, it is possible that you will not have 
access to health information about you that is created during the study until after 
the study is complete.  
If you have any questions, please contact the researcher listed on the attached 
consent form. You may also call the ASU Research Compliance Office at 480-
965-6788 with questions about the research use of your health information. Your 
researcher will give you a signed copy of this form. 
I agree to the collection, use, and sharing of my health information for purposes of 
this research study.  
 This permission will expire on September 1, 2010.  
      __   ___________________ 
Signature of research subject or subject’s legal representative   Date  
__________________________________________   ___________________ 
Printed name of research subject or subject’s legal representative      
Representative’s relationship to subject 
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Donna M. Winham, DrPH 
Arizona State University Polytechnic Campus 
Department of Nutrition 
6950 E. Williams Field Road, HSC 1401 
Mesa, AZ 85212 
Office: 480-727-1722 Fax: 480-727-1064 
 
Date:_______________________ 
 
Physician’s name: __________________________________________________ 
 
Physician’s phone number: ___________________________________________ 
 
RE: RELEASE OF MEDICAL RECORDS 
 
Patient’s name: ____________________________________________________ 
 
Date of birth: ______________________________________________________ 
 
Medical items to be released: 
_____ All records for the past 12 months previous to the date of this release 
  _____ Height/Weight 
  _____ Date of type 2 diabetes diagnosis 
 _____ Date of oral hypoglycemic medication(s) prescription (if 
applicable), type  
   of medication(s) prescribed and most recent dosage   
_____ All lab values for the past 12 months previous to the date of this release 
  _____ HbA1c 
  _____ Lipid profile 
  _____ Fasting blood glucose or results of OGTT 
  _____ Fasting insulin 
 
Signature: _________________________________________________________ 
 
Witness: __________________________________________________________ 
 
 
 
Please fax the requested information to Donna M. Winham at 480-727-1064 
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BEAN GLYCEMIC INDEX STUDY Phase III 
MEDICAL HISTORY QUESTIONNAIRE    Participant 
ID#___________________ 
Age: __________Gender: □ Male □ Female      Smoker: □Yes □ No  
Height ________ft. _________ in. Weight: _________lbs. (must weigh at least 
115 lbs). 
1. Are you taking any medications regularly? (including insulin, aspirin, etc.)
 Y N 
 
If yes, what medications and how often? _________________________ 
__________________________________________________________ 
 
2. Do you currently take supplements (vitamins, minerals, herbs, etc.)?
 Y N 
  
If yes, what supplements and how often? _________________________ 
      __________________________________________________________  
 
3.   Have you been diagnosed with diabetes within the last 6 months?  
 Y N 
 
4. Has a doctor ever told you that you have any of the following conditions: 
 Mental illness? Y N  Kidney disease? Y N 
 Liver disease? Y N  Thyroid problems? Y N 
 Eating disorders? Y N  Cancer?  Y N 
 Gastrointestinal disease or disorders? Y N 
5. Do you have a pacemaker?  Y N 
6. Are you allergic to any foods? Y N 
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 If yes, please specify _________________________________________ 
 
7. (Women Only) Are you pregnant or breastfeeding?  Y N 
 
8. Are you willing to consume black beans, pinto beans, dark red kidney  
 beans and white rice?       
 Y N 
 
9. Will you have a problem coming to ASU Polytechnic for four trial related  
 appointments, each lasting ~4 hours?     
 Y N 
 
10. Will you have a problem providing 4 venous and 7 finger-stick blood 
samples during each appointment (total amount ~ 2 tsp per appointment)? 
 Y N 
 
11. Do you have a tendency to faint when a blood sample is taken?  
  Y N 
 
12. Do you have an allergy to tape or latex (e.g., latex gloves)?   
  Y N 
 
13. Please describe any other medical conditions that may affect your 
participation on the backside of this form. 
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Type 2 Diabetes Health Survey 
 
Dietary Assessment Screener 
Think about your eating habits over the past month or so. About how often do 
you eat each of the following foods either at home or in restaurants? Mark an “X” 
in ONE box for each food. 
 
How often do you eat ... 
[A-0] 
Once per 
MONTH or 
less 
[B-1] 
2-3 times 
per MONTH 
[C-2] 
1-2 times 
per WEEK 
[D-3] 
3-4 times 
per WEEK 
[E-4] 
5 or more 
times per 
WEEK 
 
Hamburgers, cheeseburgers, ground beef 
     
 
Beef or pork, such as steaks, roasts, ribs, 
or in sandwiches 
     
 
Fried Chicken 
     
 
Hot dogs, or Polish or Italian sausage 
     
 
Cold cuts, lunch meats, ham (not low-fat) 
     
 
Bacon or breakfast sausage 
     
 
Salad Dressings (not low-fat) 
     
 
Margarine, butter or mayonnaise on bread 
or potatoes 
     
 
Margarine, butter or oil in cooking 
     
 
Eggs (not Egg Beaters or just egg whites) 
     
 
Pizza 
     
 
Cheese or cheese spreads (not low-fat) 
     
 
Whole milk (not low-fat or skim) 
     
 
French fries, fried potatoes 
     
 
Corn chips, potato chips, popcorn, 
crackers 
     
 
Doughnuts, pastries, cake, cookies (not 
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Other Foods 
If you do not know what these foods are or do not eat them, please mark the column  
for “once per month or less” 
 
How often do you eat ... 
[A-0] 
Once per  
MONTH or 
less 
[B-1] 
2-3 times  
per MONTH 
[C-2] 
1-2 times  
per WEEK 
[D-3] 
3-4 times 
 per WEEK 
[E-4] 
5 or more  
times per 
WEEK 
 
For these types of beans, include the number of times eaten as part of another dish or alone 
 
 
Black eyed peas 
     
 
Garbanzo beans, chickpeas 
     
 
Red kidney beans 
     
 
Pinto beans including refried beans 
     
 
Navy or white beans 
     
 
Baked beans; pork & beans 
     
 
Black beans 
     
 
Lentils 
     
 
Dry split peas 
     
 
Other “dried” beans: 
specify name: __________________ 
     
low-fat) 
 
Ice Cream (not sherbet or low-fat) 
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NOTE: These questions ask about what you eat each WEEK or by 
DAY, not by the month as in the previous questions. 
 
Think about your eating habits over the past month or so. About how often do 
you eat each of the following foods either at home or in restaurants? Mark an “X” 
in ONE box for each food. 
 
 
How often do you eat ... 
[A-0] 
Less than 
once per 
WEEK 
 
[B-1] 
About 1 
time per 
WEEK  
[C-2.5] 
2-3 times  
per WEEK 
[D-5] 
4-6 times 
 per 
WEEK 
[E-7] 
Once 
per 
DAY 
[F-14] 
2 or more 
times per 
DAY 
 
Fruit juice, like orange, apple, grape, 
fresh, frozen or canned (Not soda or 
other drinks) 
      
 
Not counting juice, how often do 
you eat any fruit fresh, canned, or in 
smoothies? 
      
 
Vegetable juice, like tomato juice, V-
8, carrot 
      
 
Green salad  
(like lettuce or spinach salad) 
      
 
Potatoes, any kind, including baked, 
mashed or French fried 
      
 
Vegetable soup or stew with 
vegetables 
      
 
Any other vegetables, including green 
beans, peas, tomatoes, corn, 
broccoli, or any other kind 
      
 
Fiber cereals like Raisin Bran, 
Shredded Wheat or Fruit-n-Fiber 
      
 
Dark bread such as whole wheat or 
rye 
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Bean Purchasing Habits 
 
Think about when you buy beans (dry beans, not string or green beans): 
 
 What percentage of the time do you buy beans that need to be cooked?     
________ % 
 
 What percentage of the time do you buy canned beans?                
+________ % 
 
      Should add up to 100%   
 
 
 I do not buy canned beans or beans that need to be cooked.  (check 
here) 
 
 
Think about when you buy canned beans of any type: 
 
Which brands do you usually buy?  (Check all that apply) 
 
Bush’s………………………………………………………□ 1 
Campbell’s…………………………………………………□ 2 
Rosarita…………………………………………………….□ 3 
Hormel……………………………………………………..□ 4 
S&W……………………………………………………….□ 5 
Heinz……………………………………………………….□ 6 
Van Camp’s………………………………………………..□ 7 
Ranch Style Beans…………………………………………□ 8 
Other (Please specify):……………………………………..□ 9 
   -
___________________________________________________
_   
 
Why do you buy these brands of canned beans? (Check all that apply) 
Tradition……………………………………………………□ 1 
Lower cost………………………………………………….□ 2 
100 % 
OR 
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Quality……………………………………………………...□ 3 
Recognized brand…………………………………………..□ 4 
Taste………………………………………………………..□ 5 
Nutritional value…………………………………………...□ 6 
Other (Please specify):……………………………………..□ 7 
   -
__________________________________________________ 
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APPENDIX I 
BLOCK 2005 FOOD FREQUENCY QUESTIONNAIRE 
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APPENDIX J 
24-HOUR DIET RECORD FORM 
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Food Intervention Study 
Participant Food Log 
Study Entry Form 
 
Thank you for participating in the ASU Nutrition Department Food Intervention 
Research Study. Before you begin eating the food product as part of the study, we 
want to know what you eat on ordinary days. 
Please complete the following food record as best as you can for two continuous 
days starting when you wake up. Bring the forms with you when you come in for 
your first meeting. The nutritionist will go over the forms with you and answer 
questions you may have. Handwritten forms are ok. You do not need to complete 
this on the computer. 
__________________________________________________________________ 
 
On the forms provided, please record ALL food and beverages that you consume. 
Water should be included. Please use SEPARATE FORMS for each of the two 
days. If you are receiving this as an email attachment, print two (2) copies of 
pages 3-5 so you have another form for the second day of your food record. 
Try to provide as much detail as possible about the foods or beverage that you 
consumed.  
For example, instead of listing “ham and cheese” sandwich, write out the specific 
ingredients that went into the sandwich on the lines below the item. See the 
examples below: 
 
How not to do it: 
Time of 
Meal 
Food Item Brand or 
Source 
Ingredients and/or Type 
of Preparation 
Amount 
Noon Ham and cheese 
sandwich 
 ham, cheese, bread, 
mustard, lettuce, lettuce, 
tomato 
one 
 
How we would like you to record the foods: 
Time of 
Meal 
Food Item Brand or 
Source 
Ingredients and/or Type 
of Preparation 
Amount 
Noon Ham and cheese 
sandwich 
Safeway deli ham, deli two 
slices (1 
ounce 
each) 
  Safeway deli cheese, Swiss two 
slices (1 
ounce 
each) 
  Safeway wheat bread two 
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Bakery slices 
  Kraft mustard, Dijon 1 
teaspoon 
  Kraft mayonnaise 1 
teaspoon 
   lettuce, red leaf 1 leaf 
   tomato 2 slices 
 
Where possible, please bring in the labels from convenience and/or packaged 
foods. You can attach these to your forms.  
 
Remember to include beverages (including water) and snacks that are consumed 
between meals or afterwards.  
 
Be sure to write down any supplements or medications you might be taking. 
Please attach a label for the supplement or write the information from the label on 
the record form. 
 
Time: Note the time you ate or drank an item and indicate if am or pm for clarity.  
 
Food Item: Write what the food or drink item was, e.g. crackers, casserole, 
shrimp, Coca-Cola 
 
Brand or Source: In this space, please write down what the brand name is for the 
food item or where it came from. Examples: Nabisco Wheat Thins, Burger King, 
church potluck supper, or homemade. 
 
Type of Preparation: Write down how a food was prepared if not obvious. Some 
common ways of preparing foods include baking, boiling, frying, micro waving, 
steaming or roasting. If you use oil or other sauces in preparing the food item, list 
them on a separate line. 
 
Amount: Record how much of an item you ate or drank. Example- orange juice, 6 
ounces. You do not need to weigh or measure your foods at this time. However, 
please record as much detail as you can. 
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Here is another example: 
 
Time 
(am/pm) 
Food Item Brand or Source Ingredients 
or Type of 
Preparation 
Amount 
Example: 
6:45 am 
Raisin Bran Post  ½ cup 
6:45 am skim milk Good Day  ½ cup 
6:45 am egg don’t know scrambled, 
used Pam 
nonstick 
spray  
1 large 
     
     
If you have questions or difficulties before we meet next week, please feel free to 
email me or call donna.winham@asu.edu, (480) 727-1722. I do check my email 
and voice mail frequently even on weekends. We are very excited about starting 
this project and look forward to your participation!
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DAILY FOOD LOG 
 
Date:         
 
Was this a typical day for you in terms of what you ate or drank? 
 
Yes  No (if No, What was atypical about the day?). 
_________________________________________________ 
 
 
Code #       Day of the Week: M T W Th 
F S Sun 
(Nutritionist will fill in)       (Circle 
one) 
 
Please write down ALL food and beverages (including water) you eat throughout 
the day. Remember to give as many details as possible. Please list any vitamins or 
mineral supplements (include herbal supplements, protein supplements, etc.). 
Attach labels of food products and supplements if possible. 
 
Food Record Page 1 of __________ 
 
Time 
(am/pm) 
Food Item Brand or 
Source 
Ingredients or 
Type of 
Preparation 
Amount 
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Food Record Page 2 of __________ 
 
Time 
(am/pm) 
Food Item Brand or 
Source 
Ingredients or 
Type of 
Preparation 
Amount 
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
Please record any dietary supplements or vitamins taken on this day: 
 
Brand    dosage (potency)   number of 
tablets/amount: 
 
__________________________________________________________________ 
 
__________________________________________________________________ 
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APPENDIX K 
DIETARY TREATMENT RANDOMIZATION 
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BGRIII Participant Randomization 
Subject # TX 1 TX 2 TX 3 TX 4 
401 2 1 4 3 
402 3 2 1 4 
403 2 1 3 4 
404 2 3 4 1 
405 4 2 1 3 
406 1 2 3 4 
407 1 4 2 3 
408 2 1 3 4 
409 1 2 4 3 
410 1 4 3 2 
411 3 4 1 2 
412 3 1 4 2 
413 4 2 3 1 
414 4 3 2 1 
415 1 4 3 2 
416 3 4 2 1 
417 4 2 3 1 
418 1 3 4 2 
419 2 1 4 3 
420 1 4 3 2 
421 2 3 4 1 
422 3 4 1 2 
423 2 4 1 3 
424 3 2 4 1 
425 1 4 2 3 
426 3 1 2 4 
427 2 3 4 1 
428 3 1 2 4 
429 3 4 2 1 
430 4 2 1 3 
 
1 = rice/rice, 2 = pinto beans/rice,  
3 = black beans/rice,4 = dark red kidney beans/rice  
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APPENDIX L 
GLUCOSE ASSAY AND BLOOD COLLECTION PROTOCOL 
YSI 2300 STAT 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
115 
Methods 
1. Calibrate the YSI 2300 by entering Run Mode or, if in Run Mode, by 
pressing the Calibrate key. 
1. Each day, prior to runs, test the linearity of the system with 0.90% w/v 
glucose using YSI 1531 (9.00 g/L glucose) linearity standard. 
2. When idle for more than 15 minutes during sampling without calibration 
(should automatically calibrate every 5 samples), initiate a calibration. 
3. Provide participant with a hand warmer approximately 5 minutes before 
their scheduled blood draw time as displayed on the digital timer. Have 
them hold the hand to be used for blood collection within this hand 
warmer until their scheduled blood draw time. 
4. Clean participant’s finger using a sterile alcohol wipe. Allow to dry and 
use a BD Microtainer lancet (Franklin Lakes, NJ) to firmly pierce the skin 
of the top of the finger.  
5. Collect about 100µl of capillary blood from the participant in a capillary 
microtube. Blood collection should be completed within 5 minutes or 
results will not be valid. 
6. Immediately after the time of the blood draw has been written in the 
subject’s file and the timer reset, walk the blood sample to the YSI STAT 
plus for analysis. 
7. Press Sample. The sipper should then move to the Manual Station. Enter 
the subject’s number and draw (e.g.  4021 for 30 minute draw).  
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8. Present the sample to the Sipper and press Sample again to begin 
aspiration.  
9. After 4 seconds the Sipper will ascend.  
10. Remove the sample container and look for results to appear within one 
minute. 
11. Write the time of the blood draw on the results printout and leave printout 
on the machine until the participant has finished all blood draws. 
